{"id":63969,"date":"2023-11-15T10:00:00","date_gmt":"2023-11-15T09:00:00","guid":{"rendered":"https:\/\/www.embl.org\/news\/?post_type=embletc-issue&#038;p=63969"},"modified":"2024-05-29T12:02:08","modified_gmt":"2024-05-29T10:02:08","slug":"issue-101","status":"publish","type":"embletc-issue","link":"https:\/\/www.embl.org\/news\/embletc\/issue-101\/","title":{"rendered":"Issue 101"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":0,"parent":0,"menu_order":0,"template":"","class_list":["post-63969","embletc-issue","type-embletc-issue","status-publish","hentry"],"acf":{"embletc_main_stories":[{"ID":63993,"post_author":"100","post_date":"2023-11-15 10:00:00","post_date_gmt":"2023-11-15 09:00:00","post_content":"<!-- wp:paragraph -->\n<p>A bassoon\u2019s rich timbre breaks the silence of a darkened auditorium, followed closely by flutes, violins, French horns, and a variety of percussion instruments. Singers enter the stage in costume, following precisely choreographed movements, their voices blending in perfect symphony. A spectacular operatic piece is underway.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>At the heart of this performance is a network of dynamical systems \u2013 systems that evolve over time according to precise rules. Unseen cues from the conductor and interactions between instruments and performers combine to create a magical performance that could have easily devolved into chaotic noise. And the key elements that govern this system are: time, timing, and transitions.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>The same three principles hold true for living systems, where even at a molecular level, thousands of processes happen at once \u2013 millions of tiny unseen operas. Developmental biologists in particular have long appreciated the critical importance of when things happen, at what pace, and how they correlate with the major transitional events of development.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>In living systems, there is an arrow of time \u2013 a history.&nbsp; For decades, scientists have recognised the importance of this notion of time, timing, and transitions in living systems. The difference these days is that technology can now not only make this \u2018time and timing\u2019 visible by revealing oscillations and rhythms, but scientists can also manipulate and therefore study these concepts in developing organisms.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>For example, a snapshot of a living system is unable to reveal \u2018timing\u2019. Instead, one must observe the systems over a long time. Over the past 10 to 20 years, this is why EMBL and other research institutes have been investing in finding ways to make timing visible, with microscopy and other tools that help us see the rhythms and associated dynamics within cells and within organisms.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>The progress in theory, imaging technology, and techniques like microfluidics, have given scientists ways to study developing systems in a much more dynamic manner \u2013 yielding findings that could even be drivers for preventing and treating developmental diseases and disorders. However, this research is fundamental, with the central goal of gaining a clearer understanding of living systems and the varied internal and external cues that provoke changes in form, function, and behaviour.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\"><strong>Where physics meets sea anemones<\/strong><\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:image {\"align\":\"left\",\"id\":64017,\"width\":\"291px\",\"height\":\"auto\",\"aspectRatio\":\"0.6513671875\",\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image alignleft size-large is-resized\"><img src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/Soham-Basu_cropped-667x1024.jpg\" alt=\"Male scientist sitting on a chair inside a laboratory\" class=\"wp-image-64017\" style=\"aspect-ratio:0.6513671875;width:291px;height:auto\"\/><figcaption class=\"wp-element-caption\">Soham Basu's interest in the theoretical physics related to dynamical systems has found its place in developmental biology. Credit: Ivy Kupec\/EMBL<\/figcaption><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:paragraph -->\n<p>Dynamical systems are not new to Soham Basu, a PhD student who moved to EMBL from Kolkata, India, transitioning from studying astronomy and theoretical physics to doing hands-on experimental biology in Aissam Ikmi\u2019s research group.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Physicists have long applied dynamical systems to studying particles, or ensembles of particles, whose states vary over time, and this was the part of theoretical physics that most captivated Basu.&nbsp;&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>From his undergraduate days of coding, running simulations, and debugging theoretical suppositions, Basu moved on to observing the early morphogenesis of the starlet sea anemone <em>Nematostella vectensis<\/em> in the lab. <em>Nematostella<\/em>, an evolutionarily ancient, simple, yet distinctive genus, doesn\u2019t exhibit signs of ageing and has regenerative capabilities.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:image {\"align\":\"right\",\"id\":64063,\"width\":\"329px\",\"height\":\"auto\",\"aspectRatio\":\"1\"} -->\n<figure class=\"wp-block-image alignright is-resized\"><img src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/image-2.jpeg\" alt=\"A microscopy image showing the mouth of a Nematostella larva. Four projections can be seen, with the endoskeleton and nuclei marked in blue and orange, respectively. \" class=\"wp-image-64063\" style=\"aspect-ratio:1;width:329px;height:auto\"\/><figcaption class=\"wp-element-caption\">The mouth of a young <em>Nematostella<\/em> larva becoming a polyp. The four projections will later form the tentacles that it would use to grab food. In blue is the endoskeleton (Collagen IV), essentially their bones to support their body structure. In orange are the nuclei that contain the genetic information. Credit: Soham Basu\/EMBL<\/figcaption><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:paragraph -->\n<p><em>Nematostella<\/em> constantly expand and contract while water is pumped through their body cavity. Basu wanted to understand how the anemones\u2019 very flexible skeletons couple with surrounding tissue and how the combination dictates the organism's tube-like shape. On small time scales, such as seconds, the continuous pumping of water doesn\u2019t have much impact on <em>Nematostella\u2019s <\/em>size, but it underlies their flexibility.&nbsp; However, on a longer time scale, the anemones keep growing incrementally, while also becoming less flexible. Basu refers to this phenomenon as a \u2018bridging of the scales\u2019.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>With support from EMBL\u2019s Advanced Light Microscopy Facility team and its microscopes, Basu follows the growth trajectory of <em>Nematostella <\/em>larvae over a 36-hour period, finding ways to zero in on specific points in the growth process and at key locations of their developing bodies and explain the incremental biophysical process that stabilises the shape of the sea anemone at each step.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cAt this point, we have a beautiful story of how interactions are happening,\u201d Basu said. \u201cAnd, in a way, I\u2019m coming full circle, now collaborating with a theoretical biophysicist, who is well known for his work in morphogenesis.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\"><strong>Synchronicity and the rhythm of cells<\/strong><\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Each of us begins life as a single cell, which then divides into a mass of undifferentiated cells. Bit by bit, these undifferentiated cells get assigned functions and positions, and take these up to give rise to a specific shape per a body plan. This basic understanding is at the crux of the work of several researchers in Alexander Aulehla's research group, including Simona Gio\u00e8 and Sarkis Tafnakaji, both PhD students; and Simon Knoblich, a trainee who came to EMBL from medical school.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:image {\"id\":64061} -->\n<figure class=\"wp-block-image\"><img src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/image-1.jpeg\" alt=\"Three scientists standing inside a laboratory. The female scientist on the left is holding what looks like a set of narrow tubing. \" class=\"wp-image-64061\"\/><figcaption class=\"wp-element-caption\">(Left to right) Simona Gio\u00e8, Simon Knoblich, and Sarkis Tafnakaji, from the Aulehla group, are particularly interested in the synchronicity of events that occur just as undifferentiated cells get assigned functions per the body plan. Credit: Kinga Lebowiecka\/EMBL<\/figcaption><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:paragraph -->\n<p>During development, each cell needs to know what to do and when to do it in coordination with everything that is going on. Gio\u00e8, Tafnakaji, and Knoblich are studying these timing cues and the larger impact they have on an organism\u2019s development.&nbsp;&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cIn my research, I am looking at the timing of somite formation (the precursors to vertebrae) and trying to figure out what else is being controlled by this timing \u2013 is it just the time when things form, or does it influence the shape they will have?\u201d said Gio\u00e8, who comes to EMBL from Italy.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Gio\u00e8 uses a technique called microfluidic entrainment to manipulate the tempo of a \u2018segmentation clock\u2019 that dictates the rate of skeletal formation in mice embryos.&nbsp; Microfluidics involves the precise control and manipulation of flows with miniaturised devices. Using such a system, she periodically flushes the embryo with drugs that slow down or speed up development and then observes developmental consequences, such as changes in shape in the developing mice. In her current work, she looks specifically at signalling via the Notch pathway that not only is central to normal development but has been connected to tumour development.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Gio\u00e8 follows skeletal development over 24 hours, taking images every 10 minutes. She then uses these images to reconstruct the time series and better understand the interconnectedness of the dynamics occurring at any given point. With this method, she is able to observe something not visible normally because it happens inside the uterus. The microfluidics bring it \u2018ex vivo\u2019 so she can capture a \u2018sweet spot\u2019 of imagery to see otherwise unknown nuances and analyse the dynamics in a manageable way.&nbsp;&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Likewise, Knoblich, who comes to EMBL from Austria, is applying this same microfluidics approach to Japanese rice fish (medaka) for his research. He hopes to better understand the segmentation clock in a non-mammal vertebrate model.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Medaka embryos usually develop in the brackish water of rice fields in Japan. While the average water temperature is 28\u00b0C, embryos can experience seasonal and daily temperature fluctuations ranging from 10\u00b0C to 35\u00b0C. Despite these drastic conditions, medaka embryonic development has been shown to be remarkably robust. Knoblich is trying to gain an understanding of the segmentation clock, which is typically set to produce a new segment or somite every 80 minutes at 27\u00b0C. This is a faster model organism than the mouse, and comes with a wide array of genetic tools that offer Knoblich a variety of options for manipulating and viewing the transparent fish embryos.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:image {\"align\":\"left\",\"id\":64021,\"width\":\"264px\",\"height\":\"auto\",\"aspectRatio\":\"0.5634765625\",\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image alignleft size-large is-resized\"><img src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/Killifish-larvae-577x1024.jpg\" alt=\"A petri dish containing a large number of killfish embryos. \" class=\"wp-image-64021\" style=\"aspect-ratio:0.5634765625;width:264px;height:auto\"\/><figcaption class=\"wp-element-caption\">Simon Knoblich is expanding his research to include <em>Nothobranchius furzeri <\/em>killifish embryos that are able to enter diapause, which allows them to survive annual dry periods and environments hostile to other fish species, much like in this petri dish that contains killifish embryos for his research. He is interested in connecting his observations in medaka with the related species to gain an understanding of developmental timing in these unique species. Credit: Ivy Kupec\/EMBL<\/figcaption><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:paragraph -->\n<p>In another project, Knoblich looks specifically at the very first stages of embryo development when medaka and other teleost (related ray-finned fish) embryos spread over their yolk in a fairly short span of time, undergoing significant morphogenetic and developmental changes. Knoblich is particularly interested in the collective calcium signalling that occurs in waves and that traverses throughout entire embryos at this stage.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cWhat I\u2019ve found interesting is the comparative nature of this research,\u201d Knoblich said. \u201cIt\u2019s why I\u2019m looking at doing similar experiments with killifish that experience diapause, a condition which suspends development and allows them to survive annual dry periods and environments hostile to other fish species. Despite being closely related to medaka, killifish go through very different early developmental stages that can span days to months (as opposed to hours in medaka), for reasons, and with biological mechanisms, not entirely understood yet.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Tafnakaji\u2019s work also is connected to Knoblich and Gio\u00e8\u2019s research projects in that he wants to know how the dynamic signalling involved in somite formation instructs the developmental progress and subsequent differentiation.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Tafnakaji, who grew up in Armenia and Syria and came to EMBL after R&amp;D research at AstraZeneca in Sweden, was also inspired by the segmentation clock.&nbsp; Wave-like signals across the developing tissue provide many cues for the cells. His work explores which of these cues are most relevant for the cells to synchronously and precisely form somite structures. Working with Gio\u00e8, Tafnakaji explores also how the change of timing in cellular communication can instruct the patterning of a developing embryo body.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Understanding these aspects of cell communication helps inform basic questions like, \u2018If you have a group of identical cells, what are the different ways we might instruct them to create new, different types of tissues or structures?\u2019<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cThis is curiosity-driven fundamental information that will help us later in realising our full potential in any sort of field in which cells are the building blocks, such as tissue engineering or cellular therapeutics,\u201d Tafnakaji said. \u201cThis can be foundational work for anything we want to do that is cell-based.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\"><strong>Studying key transitional moments in development<\/strong><\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Just as Knoblich looks specifically at the very first stages of embryo development and the collective waves there, so do the researchers in Nicoletta Petridou\u2019s group at EMBL Heidelberg.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>The survival of the embryo is critically dependent on certain key transitions that occur early in development. Lena Schindler and Camilla Autorino, PhD students in the Petridou group, are focusing on a very short transitional window in zebrafish embryo development that may provide important clues to the biophysical interactions that shape this process.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Schindler and Autorino are exploring the biological functions of tissue transitions in development \u2013 work inspired by Petridou\u2019s postdoc research at the Institute of Science and Technology, Austria. Petridou joined EMBL in 2020 and is originally from Cyprus. While observing the very first movement that embryonic tissue undergoes during development, she noticed a rapid transition where the tissue goes essentially from a solid to fluid state, and the cells\u2019 collective resistance to flow abruptly drops.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:image {\"id\":64015,\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/Develomental-Biology_Lena-Schindler-and-Camilla-Autorino_10718-Edit-Edit-1024x683.jpg\" alt=\"Two female scientist looking at a tank containing zebrafish. An overlay shows steps in zebrafish embryonic development.\" class=\"wp-image-64015\"\/><figcaption class=\"wp-element-caption\">Lena Schindler and Camilla Autorino may be looking at adult zebrafish here, but their research focuses on key transitional moments in zebrafish embryonic development in EMBL's Petridou group. Credit: Stuart Ingham\/EMBL<\/figcaption><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:paragraph -->\n<p>The scientists describe this as a fluid state because the material state is measured based on its viscosity. Initially, when pipetted, the tissue shows high resistance and doesn't quite \"flow\" up the pipette (like honey). Once the transition has happened, it is much more deformable and moves up the pipette quickly (more like water). Later, it changes back to a less deformable state.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Petridou\u2019s work brought her in contact with Bernat Corominas-Murtra, a physicist at the University of Graz, Austria, who was also studying phase transitions, albeit not in biological systems. Petridou applied a mathematical framework from 1864 that used the concept of networks to understand real material properties of embryonic tissues. This subsequently helped shape her research direction.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cImagine an iron bridge composed of lots of bars. You don\u2019t have to remove all the bars for the bridge to collapse; it may only require a few bars being removed,\u201d Petridou explained. \u201cSo, then, instead imagine this breach is happening in a network of cells and links between cells. As links are removed, the whole network becomes unstable, vulnerable to breaking.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Petridou soon found that the minimum number of connections required to break a network, as predicted in the mathematical theory from 1864, matched what she found to be true in tissues as well. And rather than activity just <em>within <\/em>the cell, a cell\u2019s connections to other cells determined the key solid-to-fluid transition of the tissue.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>This approach has informed a lot of the Petridou group\u2019s work on critical transitional moments in embryo development, where tiny cellular manipulations can have a tissue-scale effect, simply by disrupting the synchronicity between biological processes. As connections between cells change, transitions occur because collective tissue properties are changing too. The group is still investigating if and how cells respond to their environment and its changes.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cI think this is what is so interesting;&nbsp; you don't have a steady state,\u201d said Autorino, who joined Petridou\u2019s group in 2020 and is originally from Italy. \u201cThe system keeps changing. In 10, 15, or 20 minutes, you create a new normal. And then it changes again.\u201d&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>In that 10-minute period when zebrafish embryos are just beginning to set up their body plan, the tissue of the future embryo spreads and starts to cover the yolk while the yolk \u2018domes\u2019 upward into it to assist the process, as seen in the video here.&nbsp; Schindler, who came to EMBL from Austria, wants to better understand how cells work together to form tissues, and uses this key transition to understand how the synchronisation between cell divisions in the embryo (or lack thereof) can help regulate this process.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:video {\"id\":64049} -->\n<figure class=\"wp-block-video\"><video controls src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/2022_12_17-03_AcquisitionBlock3_pt3-1.mp4\"><\/video><figcaption class=\"wp-element-caption\">During the onset of morphogenesis the zebrafish embryo undergoes tissue scale rearrangements. At the same time, the cells close to the yolk start the path towards differentiation (visible in green through the fate marker Sebox). Cell membranes are in red, and nuclei in blue. Live imaging like this allows the scientists to monitor both tissue and cellular scale properties throughout developmental transitions. Credit: Camilla Autorino\/EMBL<\/figcaption><\/figure>\n<!-- \/wp:video -->\n\n<!-- wp:paragraph -->\n<p>\u201cBasically, I draw connections from the spaces between the cells,\u201d Schindler said. \u201cI can follow along as they divide cell by cell, sorting cells that are connected and creating maps that our mathematical collaborators then can use to compute correlations.\u201d&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Autorino\u2019s work, on the other hand, focuses on a very specific region of the embryo that is the first to have its \u2018fate\u2019 determined; it marks the first signalling events happening in the tissue. As this happens, Autorino also observes mechanical and material property changes. Consequently, she aims to characterise how these mechanical and material properties affect what the cells ultimately transform into.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>As recently as five years ago, one would be hard-pressed to find scientific literature about applying phase transition research in developing systems. But this approach has even broader applications. Metastasis in cancer cells, Petridou explains, is basically a transition of a solid tumour to a gas because the density of the cells becomes so sparse. On a much larger scale, avalanches, ecosystem transitions, and climate changes are also ripe for studying in this way.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\"><strong>When time, timing, and transitions entangle<\/strong><\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:image {\"id\":64023,\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/Alexander-Aulehla-1024x576.jpg\" alt=\"A male scientist in front of a chalkboard.\" class=\"wp-image-64023\"\/><figcaption class=\"wp-element-caption\">The head of EMBL's Developmental Biology unit, Alexander Aulehla, outlines the central questions around time, timing, and transitions that are addressed in different contexts across EMBL\u2019s Developmental Biology unit. Credit: Ivy Kupec\/EMBL<\/figcaption><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:paragraph -->\n<p>The overlap between many of these research projects seems inevitable. Transitions depend on the synchronisation of multiple systems, and all such processes are controlled in space and also in time.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cThere\u2019s a very fundamental way that life is organised, and the notion of time and timing is at the heart of it,\u201d said Alexander Aulehla, the head of EMBL\u2019s Developmental Biology unit. \u201cWithin our bodies, we have different rhythms in different parts of our bodies, and these are coordinated.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Aulehla is in turn fascinated with this natural synchronicity, seen across scales in biological systems.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cEven after an opera, think of the way a standing ovation takes over an audience,\u201d he said. \u201cYou are just part of this moment that becomes synchronised with no maestro directing you.&nbsp; And that\u2019s the kind of coordination that is happening between cells in every early embryo.\u201d<\/p>\n<!-- \/wp:paragraph -->","post_title":"Why time is of the essence in development","post_excerpt":"EMBL developmental biologists \u2013 with help from other disciplines \u2013 pursue the significance of time, timing, and transitions in organisms during their development","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"why-time-is-of-the-essence-in-development","to_ping":"","pinged":"","post_modified":"2023-11-15 10:13:44","post_modified_gmt":"2023-11-15 09:13:44","post_content_filtered":"","post_parent":0,"guid":"https:\/\/www.embl.org\/news\/?post_type=embletc&#038;p=63993","menu_order":0,"post_type":"embletc","post_mime_type":"","comment_count":"0","filter":"raw"}],"embletc_main_story_subheading":"","embletc_main_story_teaser":"<p>Developmental biologists have long appreciated the critical importance of when things happen, at what pace, and how they correlate with the major transitional events of development. With progress in theory, imaging technology, and techniques like microfluidics, scientists are now able to study developing systems in a much more dynamic manner \u2013 yielding findings that could even be drivers for preventing and treating developmental diseases and disorders. Fundamental research conducted by scientists at EMBL Heidelberg is helping us gain a clearer understanding of living systems and the varied internal and external cues that provoke changes in form, function, and behaviour.<\/p>\n","embletc_main_story_image":{"ID":63971,"id":63971,"title":"Composition_large_final","filename":"Composition_large_final-scaled-e1699000132655.jpg","filesize":699333,"url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/Composition_large_final-scaled-e1699000132655.jpg","link":"https:\/\/www.embl.org\/news\/embletc\/issue-101\/attachment\/composition_large_final\/","alt":"","author":"124","description":"During an organism's development, at a molecular level, thousands of processes happen at once. Researchers at the Developmental Biology Unit at EMBL are studying the key role time, timing, and transitions play in this progression. Credit: Isabel Romero Calvo\/EMBL","caption":"During an organism's development, at a molecular level, thousands of processes happen at once. Researchers at the Developmental Biology Unit at EMBL are studying the key role time, timing, and transitions play in this progression. Credit: Isabel Romero Calvo\/EMBL","name":"composition_large_final","status":"inherit","uploaded_to":63969,"date":"2023-11-02 08:58:35","modified":"2023-11-03 13:40:15","menu_order":0,"mime_type":"image\/jpeg","type":"image","subtype":"jpeg","icon":"https:\/\/www.embl.org\/news\/wp-includes\/images\/media\/default.png","width":1000,"height":600,"sizes":{"thumbnail":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/Composition_large_final-scaled-e1699000132655-150x150.jpg","thumbnail-width":150,"thumbnail-height":150,"medium":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/Composition_large_final-scaled-e1699000132655-300x180.jpg","medium-width":300,"medium-height":180,"medium_large":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/Composition_large_final-scaled-e1699000132655-768x461.jpg","medium_large-width":768,"medium_large-height":461,"large":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/Composition_large_final-1024x649.jpg","large-width":1024,"large-height":649}},"embletc_main_story_hero":{"ID":63991,"id":63991,"title":"20231030_Hero_EMBLetc","filename":"20231030_Hero_EMBLetc-scaled.jpg","filesize":224946,"url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/20231030_Hero_EMBLetc-scaled.jpg","link":"https:\/\/www.embl.org\/news\/embletc\/issue-101\/attachment\/20231030_hero_embletc\/","alt":"","author":"124","description":"","caption":"","name":"20231030_hero_embletc","status":"inherit","uploaded_to":63969,"date":"2023-11-02 09:37:36","modified":"2023-11-02 09:37:36","menu_order":0,"mime_type":"image\/jpeg","type":"image","subtype":"jpeg","icon":"https:\/\/www.embl.org\/news\/wp-includes\/images\/media\/default.png","width":2560,"height":853,"sizes":{"thumbnail":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/20231030_Hero_EMBLetc-150x150.jpg","thumbnail-width":150,"thumbnail-height":150,"medium":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/20231030_Hero_EMBLetc-300x100.jpg","medium-width":300,"medium-height":100,"medium_large":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/20231030_Hero_EMBLetc-768x256.jpg","medium_large-width":768,"medium_large-height":256,"large":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/20231030_Hero_EMBLetc-1024x341.jpg","large-width":1024,"large-height":341}},"embletc_other_stories":[{"ID":63995,"post_author":"159","post_date":"2023-11-15 10:00:00","post_date_gmt":"2023-11-15 09:00:00","post_content":"<!-- wp:paragraph -->\n<p>DNA is essentially a long thread of genetic code that can be deciphered to access the fundamental instructions for life. In the late 1970s, British scientist Frederick Sanger developed a pioneering method for DNA sequencing \u2013 a breakthrough that earned him his second Nobel Prize in Chemistry in 1980. Ten years after this breakthrough, an international team of scientists set out to sequence all 3 billion letters of the human genome, launching the Human Genome Project. In 2003, two years ahead of schedule, the ambitious goal was reached, and the human genome was sequenced to 99.99% accuracy. By 2007, older sequencing technologies were supplanted by newer methods, collectively called next-generation sequencing, greatly expanding the scope of genomics research.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>The EMBL Genomics Core Facility, also known as GeneCore, has lived through this revolution in the field of genomics. The facility started out in 2001 as a Sanger sequencing provider, under the aegis of biochemist Vladimir Benes, who still leads the facility today. Twenty-two years later, it has evolved into an advanced next-generation sequencing platform.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><a href=\"https:\/\/www.embl.org\/groups\/genomics\/members\/\">The GeneCore team<\/a> currently consists of five research technicians, three bioinformaticians, two senior engineers, and several visiting fellows and associates, who are dedicated to supporting researchers across EMBL's member states. In addition to providing a wide array of advanced genomics services, the facility serves as a vital resource, facilitating groundbreaking research and fostering scientific innovation. <\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:image {\"id\":64027,\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/Genonic-Core-Facitiies_029-1024x683.jpg\" alt=\"Two GeneCore staff members looking at a liquid handling robot. \" class=\"wp-image-64027\"\/><figcaption class=\"wp-element-caption\">Ferris Jung, Senior Engineer of NGS Automation and Laura Villacorta, Research Technician, with the liquid handling robot used for automated preparation of NGS libraries. Credit: Stuart Ingham\/EMBL<\/figcaption><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:paragraph -->\n<p>At its core, the facility specialises in providing genomics technologies, with a primary focus on sequencing techniques. The platform is well-versed in the latest advancements, including what is commonly referred to as next-generation high-throughput sequencing or more accurately, massively parallel sequencing (MPS).<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cThe GeneCore team provides a complete service, from library preparation to sequencing. Beyond the regular services, Vladimir and colleagues are also helpful in developing methods where none exists,\u201d said Ramesh Pillai, Professor at the University of Geneva, Switzerland, and one of GeneCore\u2019s users.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Another strength of GeneCore is its significant reach within the scientific community in EMBL\u2019s member states. This vast network of users underscores the facility's importance and its role as a central hub for genomics research. \u201cWe are here to help people flourish in their genomics projects, and this is an element which we believe makes us stronger as a service facility,\u201d said Benes.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:image {\"id\":64029,\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/Genonic-Core-Facitiies_110-1024x683.jpg\" alt=\"A female researcher looking at an illumina sequencer. \" class=\"wp-image-64029\"\/><figcaption class=\"wp-element-caption\">Daphne Welter, Research Technician monitoring the performance of the Illumina sequencer analysing NGS libraries. Credit: Stuart Ingham\/EMBL<\/figcaption><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\"><strong>Enabling diverse user projects \u2013 from COVID-19 to the flu virus<\/strong><\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Over the course of its two decades in operation, GeneCore has made significant contributions to a diverse range of projects.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>In 2020, following the outbreak of COVID-19, scientists sequenced the genome of the SARS-CoV-2 virus, creating a significant impact on the global response to the pandemic. GeneCore played its part here, both in the development of tests for diagnostics and in the monitoring of variants. \u201cWhen the pandemic reached us, we were able to pretty quickly set up testing schemes for EMBL,\u201d said Benes. \u201cWe also participated in the sequencing of positive samples from PCR analysis for the identification of SARS-CoV-2 variants of concern. And even there, we were prepared, which is one of GeneCore\u2019s assets.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Another example is a long-standing collaboration with Stephen Cusack, former Head of EMBL Grenoble, who has been studying the influenza virus for more than 30 years, contributing to one of the most detailed descriptions of the influenza virus\u2019s RNA polymerase. \u201cCusack\u2019s group created an artificial system to unveil the influenza virus polymerase function, which needed sequencing experiments to be verified,\u201d said Benes. \u201cThey came to us and we helped them solve it. We make sure to take on every project with the same degree of commitment.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:image {\"id\":64031,\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/Genonic-Core-Facitiies_130-Edit-1024x683.jpg\" alt=\"Two female scientists seen from above using a high-resolution electrophoresis Femto instrument\" class=\"wp-image-64031\"\/><figcaption class=\"wp-element-caption\">Hilal Ozgur and Mireia Osuna Lopez, Research Technicians in the GeneCore team, using the high-resolution electrophoresis Femto instrument to check the DNA samples' integrity prior to their processing for long-read sequencing. Credit: Stuart Ingham\/EMBL<\/figcaption><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:paragraph -->\n<p>\u201cThe GeneCore team has played a central role in advancing the success of my PhD project, notably by establishing tailored capture protocols to investigate the structure of the inactive X chromosome,\u201d said Antonia Hauth, PhD student in the Heard Group at EMBL. \u201cIt is invaluable to have such experts at EMBL, whom we can always directly reach and who have extensive expertise in many (if not all) sequencing-based experiments you could wish for.\u201d&nbsp;&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>GeneCore manages an impressive volume of samples, with approximately 20,000 currently in its care, encompassing both physical specimens and data. Of these, a remarkable 10,000 samples undergo various processing methods to make them suitable for sequencing, underscoring the facility's dedication to advancing genomics within the EMBL research community.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\"><strong>Democratising model organism research and handling data<\/strong><\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Genomics technologies have advanced significantly in recent years, becoming increasingly faster and more efficient. Modern sequencers, like those based on Illumina's technology, can generate millions to billions of DNA sequences in a single run, producing terabytes of data in a matter of hours. As of today, some of the fastest high-throughput DNA sequencers can sequence the DNA of a human-sized genome (approximately 3 billion base pairs) in a matter of hours to a day.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cWe get every kind of organism, from all sorts of bacteria, fish, mice, and human samples. A couple of years ago the concept of model organisms was very biased due to their historically accessible features. With sequencing, you can have your own model organism\u201d said Benes. \u201cNext-generation sequencing has, in a way, democratised this space, by opening up access to the primary information which every organism has \u2013 the genome.\u201d&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Beyond the provision of cutting-edge technology, GeneCore actively assists researchers in taking their genomics projects to completion, ensuring they receive the guidance and support needed for success. With an end-to-end service, the facility guides the users from the experimental design to the final data analysis and interpretation of results.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cGenecore has helped me to fully understand the technicalities behind my sequencing projects and this has greatly improved the quality and throughput of my work,\u201d said Carlos Voogdt, EIPOD Postdoctoral fellow in the Zimmermann, Typas, and Zeller groups. \u201cWith their expertise and patience, they are also assisting us in the generation of high-quality whole-genome sequences of hundreds of bacterial strains.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cThe dedication of the Genecore Team leads to high-quality data that is fundamentally supporting our research questions,\u201d said Matthias Gro\u00df, Research Technician in the Zimmermann Group at EMBL Heidelberg.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>GeneCore also supports scientists in managing the impressive data volumes that come out of sequencing experiments \u2013 one single DNA sequencing run can produce data comparable to the amount of text found in more than 1 million average-sized novels, assuming each base sequenced corresponds to a letter in a book.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cTo date, GeneCore has generated more than 100 terabases of MPS sequence data for its users,\u201d said Benes. \u201cSuch data volumes can be overwhelming, and for sure, we need to interpret them, and this requires a very intimate interaction with the users. That\u2019s why GeneCore is also equipped with computational biologists and bioinformaticians. On top of that, we also train the users to interpret their own data. It\u2019s one of GeneCore\u2019s priorities to provide guidance throughout experiments.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:image {\"id\":64055} -->\n<figure class=\"wp-block-image\"><img src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/image.jpeg\" alt=\"Four sequencing machines inside the GeneCore facility\" class=\"wp-image-64055\"\/><figcaption class=\"wp-element-caption\">GeneCore sequencing room, with Illumina Sequencers running; their powerful suite provides users with adequate flexibility and throughput to meet their needs timely. Credit: Stuart Ingham\/EMBL<\/figcaption><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\"><strong>Looking ahead: the future of genomics<\/strong><\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>According to Benes, genomic sequencing of cancer cells is one of the key topics destined to be more and more relevant in the future. \u201cThere\u2019s no question that genomics will help substantially in cancer research. There are also many other diseases with genetic underpinnings, and sometimes the detail is incredibly small \u2013 like single base mutations in the DNA. This is not very easy to find, and GeneCore helps find these tiny hallmarks in genomes,\u201d he said. \u201cThe refinement of sequencing methods will also continue to advance rapidly.\u201d The facility is also poised to provide significant support for TREC Traversing European Coastlines (TREC), the flagship project of EMBL\u2019s <a href=\"https:\/\/www.embl.org\/about\/programme\/research-plans\/planetary-biology\/\">Planetary Biology<\/a> transversal theme.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cWe\u2019re seeing TREC samples coming into the facility already,\u201d said Benes. \u201cOur contribution to the project revolves around single-cell transcriptomics and DNA barcoding.\u201d For example, in collaboration with Flora Vincent, Group Leader at EMBL Heidelberg, the GeneCore team helped optimise the method for direct DNA barcoding, eliminating the need for DNA isolation.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Furthermore, working alongside Rainer Pepperkok, Director of Scientific Core Facilities and Services, EMBL, and Johan Decelle, Junior Group Leader at CNRS, the team will be spearheading single-cell transcriptome analysis.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cThe GeneCore team is also putting great effort into reducing waste as much as possible,\u201d said Gro\u00df. \u201cTheir offer to share a number of instruments and train users for those could serve as a role model for many other institutes all over Germany to become more sustainable.'<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>In a time defined by extraordinary progress in genomics and its maturing tools, Benes and the GeneCore team at EMBL will continue to shape the way we think about science and address global challenges.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cSequencing always brings the element of surprise, as it often uncovers unexpected findings, and this sense of discovery is what makes running the platform so exciting,\u201d concluded Benes.<\/p>\n<!-- \/wp:paragraph -->","post_title":"Embracing the genome sequencing revolution","post_excerpt":"EMBL\u2019s Genomics Core Facility provides end-to-end support to researchers across Europe and beyond and stands at the forefront of scientific breakthroughs.","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"embracing-the-genome-sequencing-revolution","to_ping":"","pinged":"","post_modified":"2023-11-15 10:09:56","post_modified_gmt":"2023-11-15 09:09:56","post_content_filtered":"","post_parent":0,"guid":"https:\/\/www.embl.org\/news\/?post_type=embletc&#038;p=63995","menu_order":0,"post_type":"embletc","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":63997,"post_author":"96","post_date":"2023-11-15 10:00:00","post_date_gmt":"2023-11-15 09:00:00","post_content":"<!-- wp:paragraph -->\n<p>How do cells eat? This question lies at the focus of research undertaken by the <a href=\"https:\/\/www.embl.org\/groups\/loew\/\">L\u00f6w Group<\/a> at <a href=\"https:\/\/www.embl.org\/sites\/hamburg\/\">EMBL Hamburg<\/a> and <a href=\"https:\/\/www.cssb-hamburg.de\/\">Centre for Structural Systems Biology (CSSB)<\/a>. Using structural biology methods, they explore how \u2018promiscuous\u2019 proteins enable cells to absorb nutrients, and how this could be used to make drug uptake more efficient in the future.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\"><strong>Promiscuity has more to do with nutrition than you think<\/strong><\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>To survive, living cells absorb nutrients from their environment. Their menu includes various delicacies, such as sugars, fats, and peptides, which are tiny pieces of digested proteins that cells use to build their own proteins. To capture and pull these nutrients inside, cells use dedicated transporter molecules that sit in the cell membrane.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Many molecular transporters are highly specialised, e.g. they only transport one type of sugar. But it\u2019s different for peptides \u2013 and that\u2019s where promiscuity comes into play.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Peptide transporters known as POTs (proton-coupled oligopeptide transporters) are not picky at all. In fact, they\u2019ll grab almost any peptide they find in their way, regardless of its composition and shape. This ability is described by structural biologists as \u2018promiscuity\u2019.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cHow promiscuity works has been one of the main questions in structural biology,\u201d said Christian L\u00f6w, Group Leader at <a href=\"https:\/\/www.embl.org\/sites\/hamburg\/\">EMBL Hamburg<\/a> and <a href=\"https:\/\/www.cssb-hamburg.de\/\">Centre for Structural Systems Biology (CSSB)<\/a>. \u201cPOTs are especially fascinating, because they are much more promiscuous than most other transporters. You could compare them to a lock that can be opened by many different keys. I wanted to learn how this works.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>The L\u00f6w Group are experts in structural biology of membrane proteins, in particular promiscuous nutrient transporters. Their work on different POTs, ranging from those in bacteria to those in humans, has yielded many insights that may help solve the mystery.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\"><strong>A vehicle that wraps itself around the passenger<\/strong><\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>The L\u00f6w Group explored this further in their recent work in collaboration with the <a href=\"https:\/\/www.embl.org\/groups\/marquez\/\">Marquez Team<\/a> at EMBL Grenoble and the <a href=\"https:\/\/steyaertlab.sites.vib.be\/en\">Steyaert Lab<\/a> at the Vrije Universiteit Brussel. They determined and compared the X-ray structures of a bacterial POT called DtpB while it was <a href=\"https:\/\/www.cell.com\/cms\/10.1016\/j.celrep.2023.112831\/attachment\/ef523448-0be1-45b1-b809-26969c9e0549\/mmc2\">bound to 14 dietary peptides<\/a> of different sizes, shapes, and chemical properties. They were surprised to see that during the transport, DtpB undergoes major structural changes to adapt itself to each peptide, while the structure of the peptides themselves remains largely unchanged.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cYou could compare it to a vehicle that wraps itself around the passenger to transport them. In the world of molecular biology, this is very counterintuitive,\u201d said L\u00f6w.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Further experiments brought more surprises as they showed that the peptides that most strongly bind to DtpB are poorly transported. The peptides transported most efficiently were actually the ones with moderate binding strength.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cStrong binding is like superglue that gets the peptides stuck inside DtpB and block the passage for other peptides,\u201d said Katharina Jungnickel, postdoc in the L\u00f6w Group.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>This pattern most likely also applies to POTs in humans and other species, such as those that transport dietary peptides from the gut into the bloodstream \u2013 <a href=\"https:\/\/www.embl.org\/news\/science\/structure-of-promiscuous-protein-will-help-scientists-design-better-drugs\/\">which the L\u00f6w Group studied as well<\/a>. In fact, the scientists expect that \u2018moderate binders are best\u2019 could be a more general feature of promiscuous transporters across organisms.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:video {\"id\":44016,\"align\":\"left\"} -->\n<figure class=\"wp-block-video alignleft\"><video controls src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2021\/10\/PepT1-animation.mp4\"><\/video><figcaption class=\"wp-element-caption\">POTs can be found in different organisms and cell types. For example, in the human gut, the POT called Peptide Transporter 1 (PepT1) enables the uptake of dietary peptides as well as many drugs, including antibiotics and antivirals. The structure of PepT1 in the image is based on the PDB entries: <a href=\"https:\/\/www.ebi.ac.uk\/pdbe\/entry\/pdb\/7pmw\" target=\"_blank\" rel=\"noreferrer noopener\">7PMW<\/a>,&nbsp;<a href=\"https:\/\/www.ebi.ac.uk\/pdbe\/entry\/pdb\/7pmx\" target=\"_blank\" rel=\"noreferrer noopener\">7PMX<\/a>,&nbsp;<a href=\"https:\/\/www.ebi.ac.uk\/pdbe\/entry\/pdb\/7pmy\" target=\"_blank\" rel=\"noreferrer noopener\">7PMY<\/a>&nbsp;and&nbsp;<a href=\"https:\/\/www.ebi.ac.uk\/pdbe\/entry\/pdb\/7pn1\" target=\"_blank\" rel=\"noreferrer noopener\">7PN1<\/a>. Credit: Isabel Romero Calvo\/EMBL<\/figcaption><\/figure>\n<!-- \/wp:video -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\"><strong>Promiscuity informs drug design<\/strong><\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Understanding POTs\u2019 promiscuity may be key for improving drug design.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>POTs transport many peptide-like drugs. For example, in the human gut, POTs are responsible for the uptake of various drug molecules, e.g. some drugs for hypertension, while in bacteria, they may serve as an entry point for certain antibiotics.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>However, this transport is often inefficient, so high drug doses are needed. This in turn may cause more side effects. Many potentially effective drugs might not even get transported to the right places in the body. This is one among several reasons why drugs fail in clinical trials.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cIf we could predict which drugs will be transported at early stages of drug development, this would save a lot of time and money,\u201d said Vadim Kotov, former postdoc in the L\u00f6w Group, now working in industry. \u201cThat\u2019s why we tried to crack the code that determines which peptides gets transported.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>To pursue this, the scientists combined experiments with machine learning. To their surprise, the analysis revealed that DtpB is much less promiscuous than thought before \u2013 out of the 8400 possible di- and tripeptides, it is likely to bind only a few hundred. They also identified a few factors, such as peptide size, charge and chemical properties, that are key for peptide recognition.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Using this information, the scientists have built a bioinformatics pipeline that could be used for other POTs to predict which peptides might potentially get transported and which definitely not. Eventually, this could help the pharmaceutical industry exclude poorly absorbed drugs at earlier stages of drug development. However, for more precise predictions, more research is necessary.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cIt\u2019s still a mystery what exactly the peptides need in order to be transported,\u201d said Jungnickel. \u201cAlthough it\u2019s a relatively simple system, it\u2019s harder to figure out than we thought.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cArguably, an even larger dataset would be necessary to train next-generation predictive models,\u201d added Kotov.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\"><strong>A 2-in-1 molecule<\/strong><\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Another recent study by the L\u00f6w Group in collaboration with colleagues from Boehringer Ingelheim dives into the function of another POT, called PHT1 (peptide\/histidine transporter 1). It is found in the membrane of lysosomes, cell organelles involved in \u2018digesting\u2019 defective and worn-out cellular components, among other functions. PHT1 is quite peculiar because besides transporting peptides, it can also detect signals and trigger molecular reactions inside the cell. Proteins with this ability are called receptors.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cWe never expected that PHT1 could function as a receptor,\u201d said T\u00e2nia Cust\u00f3dio, postdoc in the L\u00f6w Group. \u201cPOTs are predicted to have similar transport mechanisms and having a dual transport-receptor function was unheard of. I was really curious to understand the function of this peptide transporter in our immune system.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>While PHT1 is important for our immunity, overactivity of its receptor function may lead to autoimmune diseases, such as systemic lupus erythematosus, as well as to inflammatory bowel diseases and type 2 diabetes. Blocking PHT1 receptor function might, therefore, help treat systemic lupus erythematosus.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Designing such blocker molecules requires knowing the detailed structure of PHT1. To enable this, the L\u00f6w Group determined the molecular structure of PHT1 and mapped its interaction surface with another protein that helps PHT1 to trigger the molecular response to signals.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>This model can serve as a guide for other researchers to develop molecules that would either block peptide transport or the receptor function of PHT1.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><a><\/a>\u201cTen years of POT research at EMBL \u2013 from bacteria to humans and back \u2013 during which we obtained fantastic molecular insights into the structure and mechanisms of this important transporter family,\u201d said L\u00f6w. \u201cThe research opens up new avenues in academic settings and pharmaceutical industry. Our findings can be used to modify existing and future drugs for improved uptake or to develop small molecules to inhibit the PHT1\u2019s receptor function. The future looks bright for transporter research.\u201d<\/p>\n<!-- \/wp:paragraph -->","post_title":"The secret of molecular promiscuity","post_excerpt":"Promiscuity is critical for nourishment. How? This question lies at the focus of research by the L\u00f6w Group at EMBL Hamburg. Using structural biology methods, they explore how specialised molecules located in the cell membrane allow cells absorb nutrients from their environment.","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"the-secret-of-molecular-promiscuity","to_ping":"","pinged":"","post_modified":"2023-11-21 15:01:40","post_modified_gmt":"2023-11-21 14:01:40","post_content_filtered":"","post_parent":0,"guid":"https:\/\/www.embl.org\/news\/?post_type=embletc&#038;p=63997","menu_order":0,"post_type":"embletc","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":64001,"post_author":"77","post_date":"2023-11-15 10:00:00","post_date_gmt":"2023-11-15 09:00:00","post_content":"<!-- wp:paragraph -->\n<p>In a world inundated with data, curating valuable information has never been more challenging, or more important. From academic papers to scientific databases, the deluge of new information can be overwhelming, leaving researchers in a constant struggle to keep up. However, a groundbreaking innovation in artificial intelligence is helping to transform the data curation landscape: large language models (LLMs) such as those behind ChatGPT. Powered by sophisticated deep-learning algorithms, these models are revolutionising how we streamline and curate massive volumes of data.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Here we look at some of the ways researchers at EMBL\u2019s European Bioinformatics Institute (EMBL-EBI) are taking advantage of LLMs to aid their data curation processes. From automating the summary and annotation of academic papers to assisting with ontology mapping, LLMs are not just aiding human curators but also have the potential to enhance the quality of the data EMBL-EBI provides to its users.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:acf\/vfwp-card {\"name\":\"acf\/vfwp-card\",\"data\":{\"image_source\":\"media_library\",\"_image_source\":\"field_602ba83883d48\",\"image\":\"\",\"_image\":\"field_5ebd3243ee8ec\",\"title\":\"What are large language models (LLMs)?\u00a0\",\"_title\":\"field_5ebd3243ee989\",\"subheading\":\"\",\"_subheading\":\"field_603b4403d386e\",\"text\":\"\\u003cspan style=\\u0022font-weight: 400;\\u0022\\u003eLLMs are a type of artificial intelligence system trained on vast amounts of textual data. By processing and learning from this data, these models can generate coherent and contextually relevant text across a wide range of topics. LLMs can understand and produce human-like text, making them valuable tools for tasks such as content creation, answering questions, and natural language understanding. \\u003c\/span\\u003e\",\"_text\":\"field_5ebd3243eea26\",\"link\":\"\",\"_link\":\"field_5ebd3243eeac3\",\"style\":\"bordered\",\"_style\":\"field_5ebd3244102b1\",\"image_ratio\":\"default\",\"_image_ratio\":\"field_61d41d4bcbbee\"},\"mode\":\"preview\"} \/-->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\"><strong>Transforming data curation&nbsp;<\/strong><\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Academic papers are currently being published at an unprecedented pace, and the challenge of pulling out relevant information has never been greater. <a href=\"https:\/\/www.ebi.ac.uk\/people\/person\/andrew-green\/\">Andrew Green, ARISE Fellow at EMBL-EBI<\/a> has been using LLMs to streamline the data curation for EMBL-EBI\u2019s database for non-coding RNAs, <a href=\"https:\/\/rnacentral.org\/\">RNAcentral<\/a>.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>To do this, Green has successfully developed a tool to scrape scientific articles that mention specific RNA identifiers. These sentences are then fed into GPT-3.5, which generates concise, coherent summaries about the RNA of interest. These summaries describe key details such as the RNA's functions, its involvement in diseases, and the organisms in which it has been studied.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\"One of the intriguing features of using LLMs is the accuracy and contextual understanding they bring into the summarisation process,\" said Green. \"We've seen the model accurately decipher acronyms in a given context and even self-correct its errors when asked to fact-check its summaries.\"<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>To ensure the summaries generated are robust, they go through multiple rounds of validation, and are then rated for quality before appearing in the RNAcentral database. The summaries serve as quick references for scientists to better understand a particular RNA, and also include clickable citations to the original articles on <a href=\"https:\/\/europepmc.org\/\">Europe PMC<\/a>.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\"It's crucial to remember that LLMs don't inherently know the difference between what's real and what's fabricated,\u201d added Green. \u201cIn the scientific community, where factual accuracy is paramount, this could be a major concern. Models can sometimes 'hallucinate' details that aren't in the original text. To mitigate this, we have put multiple validation rounds in place. This, combined with constant human oversight, ensures that the information presented is both accurate and reliable.\"<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>At the heart of this approach is an automated method for extracting and summarising valuable information from a multitude of academic articles. This means that this work can also be applied to many other EMBL-EBI resources. Once fully developed and implemented, this automated process for curation serves to aid the work of many of EMBL-EBI\u2019s curators, acting as a first filter in the lengthy process of data collection and interpretation.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\"><strong>Accelerating annotation&nbsp;<\/strong><\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Another aspect of the EMBL-EBI database pipelines that can benefit from LLMs is data annotation. <a href=\"https:\/\/www.ebi.ac.uk\/people\/person\/melanie-vollmar\/\">Melanie Vollmar is an ARISE Fellow at EMBL-EBI<\/a> with a strong background in structural biology and a growing expertise in machine learning. As part of her fellowship, she is looking at how to fully automate the extraction of functional information about proteins from academic papers using LLMs.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Her project focuses on gathering structural information from the Protein Data Bank in Europe (PDBe) and supplementing it with related academic publications from Europe PMC. This curated information is then mined for specific functional details, which are mapped back onto the protein sequences listed in <a href=\"https:\/\/www.uniprot.org\/\">UniProt<\/a>.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Until now, curating literature for functional annotations followed a purely manual approach supplemented by traditional text mining methods. LLMs, designed to grasp the intricacies of human language, can parse through vast amounts of scientific literature, weigh contrasting opinions, and generate complex text-based outputs.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>This capability can bring in a new era of data enrichment, as these models help to extract more detailed and contextually rich information from existing biological literature at an accelerated pace. At no point is such a model intended to replace the human biocurator who is required to provide a critical view on the produced output.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cWith automation, not only do we increase the pace at which we can annotate data, but we also enrich the quality of that data, offering a more comprehensive resource for our users,\u201d said Vollmar. \u201cOur focus now is on protein structures, but the beauty of our approach is its adaptability: the methods we're developing could easily be transplanted onto other types of biological data, elevating the annotation process across the board.\"<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\"><strong>Fine-tuning existing LLMs&nbsp;<\/strong><\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Europe PMC is EMBL-EBI\u2019s home of scientific literature, and after many years of serving the scientific community, the resource remains an intuitive and powerful search tool to help users stay on the cutting edge of science. Many of the database's functionalities rely on literature curation, which involves scanning through dense academic material to extract essential information.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><a href=\"https:\/\/www.ebi.ac.uk\/people\/person\/santosh-tirunagari\/\">Santosh Tirunagari, Senior Machine Learning Developer<\/a> at EMBL-EBI is leveraging the capabilities of LLMs to accelerate the curation of scientific literature within Europe PMC. He and others in the team have developed specialised named entity recognition models, which are fine-tuned versions of existing LLMs. These sophisticated tools are designed to automatically identify critical scientific entities such as genes, proteins, diseases, and chemicals in research papers and patents.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Using this approach helps to side-step the high computational costs of developing a language model from scratch, which could require dozens of GPUs and extensive training time. By concentrating on the fine-tuning phase, Tirunagari has been able to adapt these powerful language models to specific tasks relevant to scientific curation. This maximises efficiency while achieving high levels of accuracy.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>In one of his models, Tirunagari also uses an innovative \u2018human-in-the-loop' methodology for model training. Beginning with a limited dataset, the fine-tuned models undergo further adjustments using additional scientific papers. Human curators then verify the model's findings, enabling an iterative feedback loop that continually improves the model\u2019s accuracy.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\"Large language models have been a game-changer in our efforts to automate the complex task of scientific curation. By fine-tuning these models, we've been able to develop highly specialised tools that can sift through vast amounts of scientific literature and patents to identify key entities such as genes, organisms, proteins, and diseases with impressive accuracy,\u201d said Tirunagari. \u201cThis not only accelerates our work but also opens up new possibilities for collaborations, like our ongoing partnership with Open Targets to use these models to aid drug discovery.\"<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\"><strong>A novel approach to ontology mapping&nbsp;<\/strong><\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Ontologies are structured, hierarchical classifications that are widely used for standardising diseases. Current practices for ontology mapping rely heavily on manual curation, making it a time-consuming and error-prone task. To address these issues, <a href=\"https:\/\/www.ebi.ac.uk\/people\/person\/kirill-tsukanov\/\">Kirill Tsukanov, Senior Bioinformatician at EMBL-EBI<\/a>, has developed a new method for ontology mapping using openly-available, GPT-based language models.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:acf\/vfwp-card {\"name\":\"acf\/vfwp-card\",\"data\":{\"image_source\":\"media_library\",\"_image_source\":\"field_602ba83883d48\",\"image\":\"\",\"_image\":\"field_5ebd3243ee8ec\",\"title\":\"What is ontology mapping?\u00a0\",\"_title\":\"field_5ebd3243ee989\",\"subheading\":\"\",\"_subheading\":\"field_603b4403d386e\",\"text\":\"Ontology mapping is when you have data in one format and you want to convert it to another standard format so that it can be combined with other data. For example, if one database uses \\u0022heart disease\\u0022 and another uses \\u0022cardiovascular disorder,\\u0022 ontology mapping would help align these terms so the databases can work together.\",\"_text\":\"field_5ebd3243eea26\",\"link\":\"\",\"_link\":\"field_5ebd3243eeac3\",\"style\":\"bordered\",\"_style\":\"field_5ebd3244102b1\",\"image_ratio\":\"default\",\"_image_ratio\":\"field_61d41d4bcbbee\"},\"mode\":\"preview\"} \/-->\n\n<!-- wp:paragraph -->\n<p>The new method integrates EMBL-EBI\u2019s <a href=\"https:\/\/www.ebi.ac.uk\/ols\/index\">Ontology Lookup Service (OLS)<\/a> with GPT-3.5 to evaluate the relevancy of ontology terms provided by OLS. Rather than generating ontology identifiers from scratch, the GPT model is tasked with grading existing mappings. This new workflow enables the system to map about 20% more terms compared to existing methods while retaining the same accuracy.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\"Our prototype already shows immense promise,\u201d said Tsukanov. \u201cThe integration of GPT models helps us overcome the limitations of existing systems, increasing the speed of ontology mapping. The application of LLMs in our research is not just innovative; it's transformative. These models are helping us bridge the gap between raw, unstructured information and actionable, standardised data.\"<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\"While LLMs like GPT-3.5 have proven to be invaluable in tasks like ontology mapping, they present an intriguing challenge,\u201d continues Tsukanov. \u201cThese models don't inherently know the difference between fact and fiction. Recognising this, we've been careful to integrate additional layers of validation and are exploring the use of open-source, stable models that can be fine-tuned specifically for our ontological needs. The goal is to have a tool that not only understands human language but aligns that understanding with the precise, standardised terms in our ontologies.\"<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>The project is currently in its developmental phase but Tsukanov plans to test the stability of other LLMs to further improve this new system. The ultimate goal is to create a universally applicable library, serving as a foundation for ontology mapping for different EMBL-EBI initiatives.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\"><strong>Large language models: a catalyst for change<\/strong><\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>The advent of LLMs such as GPT represents a pivotal moment not only in the field of artificial intelligence but also in how we handle, curate, and understand enormous volumes of data. The success stories above show that, while not without their challenges, LLMs hold immense promise for making our data-rich world more understandable, accessible, and usable.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>There are obstacles to overcome, one of the foremost concerns is data integrity and trustworthiness: as LLMs are trained on massive datasets, there's a risk of perpetuating inaccuracies or biases present in the source data. This is particularly critical in scientific applications where incorrect or biased information could have far-reaching implications. Additionally, the automated nature of LLMs could lead to unintended consequences, such as the omission of nuanced insights that human experts might catch, thereby impacting the quality and reliability of curated data.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Given these complexities, it's crucial to integrate ethical considerations into the design, implementation, and ongoing management of LLMs in scientific data curation.To address these challenges, our researchers discuss how they have implemented multi-layered verification frameworks for data curated by LLMs. Regular updates to the LLMs themselves, coupled with continuous feedback loops with human curators, allow for ongoing refinement of the models, reducing the likelihood of errors over time.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>As LLMs become an increasingly integral part of scientific research, vigilance in maintaining data quality remains a top priority. As the technology matures and as we get better at integrating human expertise with machine capabilities, these challenges are likely to diminish. Ultimately, LLMs have the potential to act as powerful catalysts in the evolution of data curation and scientific research, propelling us into an era where data can not only inform but also enhance our pursuit of understanding.<\/p>\n<!-- \/wp:paragraph -->","post_title":"Deciphering the data deluge: how large language models are transforming scientific data curation","post_excerpt":"Large language models are changing the way we carry out scientific data curation, annotation, and research, setting the stage for a more efficient understanding of scientific literature\n","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"deciphering-the-data-deluge-how-large-language-models-are-transforming-scientific-data-curation","to_ping":"","pinged":"","post_modified":"2023-11-15 10:09:02","post_modified_gmt":"2023-11-15 09:09:02","post_content_filtered":"","post_parent":0,"guid":"https:\/\/www.embl.org\/news\/?post_type=embletc&#038;p=64001","menu_order":0,"post_type":"embletc","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":64003,"post_author":"124","post_date":"2023-11-15 10:00:00","post_date_gmt":"2023-11-15 09:00:00","post_content":"<!-- wp:paragraph -->\n<p>The Kristineberg Center for Marine Research and Innovation sits near the mouth of the Gullmar fjord in Sweden. One day in early August this year, a large truck rolled up the narrow streets of the small settlement, coming to a halt only a few meters from the water. One of those most eagerly awaiting the truck\u2019s safe arrival was biologist Niko Leisch.&nbsp;&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cThere were a couple of areas where I was not sure if the truck will actually manage to make the narrow turns,\u201d said Leisch, who is currently the Operational Manager of EMBL\u2019s mobile services. \u201cI was very relieved when it finally made it.\u201d&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>With a sturdy frame, expandable walls, and scientific equipment worth several million euros, the truck that arrived at Kristineberg \u2013 the EMBL Advanced Mobile Laboratory (AML) \u2013 is a unique undertaking in the history of European life science research. The AML brings cutting-edge technology directly to the field, helping researchers process biological samples immediately after collecting them, using a variety of advanced methodologies.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:acf\/vfwp-embed {\"name\":\"acf\/vfwp-embed\",\"data\":{\"url\":\"https:\/\/www.youtube.com\/embed\/jepbtufJrIg?si=anh8uW1zSQbirlJ-\",\"_url\":\"field_5ecbb005d2d93\",\"caption\":\"\",\"_caption\":\"field_5ecbb0e7d2d94\",\"ratio\":\"16 x 9\",\"_ratio\":\"field_5ecbb0f3d2d95\"},\"mode\":\"preview\"} \/-->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\"><strong>Exploring symbiosis in the wild<\/strong><\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>One of the first users of the AML at Kristineberg was Flora Vincent, Group Leader at EMBL Heidelberg. Vincent, a marine biologist and no stranger to fieldwork, is interested in exploring the complex interactions within microbial communities, especially those involving symbiosis in single-celled microorganisms.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>As part of the Traversing European Coastlines (TREC expedition) \u2013 a flagship project of EMBL\u2019s Planetary Biology Transversal Theme \u2013 Vincent has been collecting species across land-water interfaces along the European coast. A particular point of interest for Vincent\u2019s group is diatoms, small microscopic organisms that live in the ocean and produce a large proportion of the planet\u2019s oxygen supply.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cI use a lot of single-cell approaches, particularly single-cell sequencing,\u201d said Vincent. \u201cIn the past, I have sometimes needed to collect water samples and then drive two hours to a hospital with a flow cytometry unit to do my single-cell sorting. Here, with the cell sorter in the AML, it makes it much easier to begin the process on the spot, with a much lower risk of sample damage.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:acf\/vfwp-card {\"name\":\"acf\/vfwp-card\",\"data\":{\"image_source\":\"media_library\",\"_image_source\":\"field_602ba83883d48\",\"image\":\"\",\"_image\":\"field_5ebd3243ee8ec\",\"title\":\"What is TREC?\",\"_title\":\"field_5ebd3243ee989\",\"subheading\":\"\",\"_subheading\":\"field_603b4403d386e\",\"text\":\"With the ambitious aim of sampling soil and water at 120 sites in 46 regions across Europe within two years, the TREC expedition aims to study life across all biological scales and help provide solutions to some of the most pressing global challenges of the day. Launched in March 2023, TREC brings EMBL researchers together with many partners and collaborators to investigate life at land-sea transects all along the European coast.\",\"_text\":\"field_5ebd3243eea26\",\"link\":\"\",\"_link\":\"field_5ebd3243eeac3\",\"style\":\"bordered\",\"_style\":\"field_5ebd3244102b1\",\"image_ratio\":\"default\",\"_image_ratio\":\"field_61d41d4bcbbee\"},\"mode\":\"preview\"} \/-->\n\n<!-- wp:paragraph -->\n<p>Also interested in symbiosis is Johan Decelle, Group Leader at CNRS in the Cell and Plant Physiology Laboratory, Grenoble and one of the collaborators for TREC. \u201cMy experience with the AML was like a scientific dream coming true,\u201d he said. \u201cNot only was it a unique scientific experience with cutting-edge instruments on the field, but also a memorable human adventure with experts and colleagues in the field.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:image {\"align\":\"left\",\"id\":64043,\"width\":\"440px\",\"height\":\"auto\",\"aspectRatio\":\"1.3368983957219251\",\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image alignleft size-large is-resized\"><img src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/TREC-Drone-1-1024x767.jpg\" alt=\"An overhead drone image showing the AML making its way through a narrow hilly road in Sweden. \" class=\"wp-image-64043\" style=\"aspect-ratio:1.3368983957219251;width:440px;height:auto\"\/><figcaption class=\"wp-element-caption\">The AML arriving in Kristineberg, Sweden. Credit: EMBL<\/figcaption><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:paragraph -->\n<p>Decelle\u2019s team also participated in previous TREC pilot expeditions in Iceland, France, and Italy, and this work was significant in helping shape the current version of the AML.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cWe know little about the structural organisation of these systems, or how the host cell integrates with the photosynthesising cell or machinery at the subcellular level,\u201d said Decelle, \u201cThese organisms can\u2019t be easily cultured in the lab, and we wanted to explore these symbiotic relationships in their natural environment and physiological state, freezing them for 3D electron microscopy \u2013 which we can now do with some of the instruments in the AML.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Decelle\u2019s team is also studying symbiosis in plankton \u2013 small unicellular ocean-living organisms, especially focusing on known symbiotic associations between photosynthetic and non-photosynthetic eukaryotic cells. Similar symbiotic interactions are believed to have taken place several times during evolution, leading to the acquisition of chloroplast \u2013 a key cell organelle responsible for photosynthesis \u2013 in lineages of plants and photosynthetic algae.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:image {\"align\":\"right\",\"id\":64529,\"width\":\"504px\",\"height\":\"auto\",\"aspectRatio\":\"1.6722408026755853\",\"sizeSlug\":\"full\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image alignright size-full is-resized\"><img src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/IMG_9453_EDIT_1000x600px-1.jpg\" alt=\"\" class=\"wp-image-64529\" style=\"aspect-ratio:1.6722408026755853;width:504px;height:auto\"\/><figcaption class=\"wp-element-caption\">The AML at Kristineberg. Credit: Tina Wiegand\/EMBL<\/figcaption><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:paragraph -->\n<p>According to Vincent, the AML also provides researchers an opportunity to think creatively, with tools now being available on the field that were never possible before. \u201cIt's pushing us to think about a field sampling in a different way,\u201d she said. \u201cIt really enables me to draw new paths in my brain, ones that I could have never thought of as possible in the natural environment. It also gives us the opportunity to combine the best of two worlds by using the AML tools on samples collected by the Tara schooner. In a single day, we can get a full picture of the marine microbiome thanks to the Tara holistic sampling strategy, and then leverage the AML to conduct state-of-the-art molecular and cellular analyses on targeted species\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>This is particularly suited to Vincent\u2019s team, who use an adaptive sampling approach where the research strategy is tailored to the collection of living organisms that each sample contains, rather than vice versa.&nbsp;&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cThe challenge is that we are really building the plane as we fly it,\u201d said Vincent. \u201cA lot of the machines are on the field for the first time. Each of those machines can be used in a standalone manner, but where I have a lot of fun is building connections between those tools.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Using these tools and creating such new symbiotic relationships between methodologies and scientific approaches, the researchers hope to arrive at new insights that could help address some of the most pressing global challenges we face today \u2013 climate change, environmental degradation, and biodiversity loss.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:acf\/vfwp-embed {\"name\":\"acf\/vfwp-embed\",\"data\":{\"url\":\"https:\/\/www.youtube.com\/embed\/ryPPHPxuB2k?si=muncAPAo04MiT6aK\",\"_url\":\"field_5ecbb005d2d93\",\"caption\":\"\",\"_caption\":\"field_5ecbb0e7d2d94\",\"ratio\":\"16 x 9\",\"_ratio\":\"field_5ecbb0f3d2d95\"},\"mode\":\"preview\"} \/-->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\"><strong>Peering deeper inside plankton<\/strong><\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Another researcher interested in exploring plankton communities is Omaya Dudin, group leader at the Swiss Federal Institute of Technology Lausanne (EPFL). Dudin\u2019s lab explores the evolutionary origins of animal development and is part of the expansion microscopy (PlanExM) team that, as part of TREC, is trying to create an atlas of plankton biodiversity along European coasts. They hope to create a snapshot that would be crucial in assessing the impact of climate change on these populations in the future.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cThe biggest problem that happens in environmental sampling is that the moment you go beyond an hour or two from the time of sampling, you\u2019re not really sure what you\u2019re looking at any more,\u201d said Dudin.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>This is because many of the plankton living in coastal waters tend to die quickly when taken out of their native environment, greatly altering the species composition of the sample depending on how much time has passed since collection.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>The ability of the AML to travel very close to sampling locations allows Dudin and his team to expedite these crucial sample preservation steps and image plankton at the sub-cellular resolution using expansion and electron microscopy. It is also critical for the second part of the team\u2019s work, which focuses on culturing some of the species collected from the environment in order to potentially bring them back to the lab to study.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cEMBL is very well known for having high-end techniques in microscopy and molecular biology, and to bring them here, to a place where the samples are fresh, is something very unique,\u201d said Rainer Pepperkok, Director of Scientific Core Facilities and Services at EMBL. \u201cThis is something that I think will set the basis, for many decades, of functional and mechanistic research that integrates these different domains \u2013 the sea and the land \u2013 and to understand how these molecular ecosystems are functioning.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:image {\"align\":\"right\",\"id\":64045,\"width\":\"442px\",\"height\":\"auto\",\"aspectRatio\":\"1.3350717079530638\",\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image alignright size-large is-resized\"><img src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/DJI_0205-13-1024x767.jpg\" alt=\"A drone image showing an overhead view of the AML truck parked close to the shore at Kristineberg, Sweden. \" class=\"wp-image-64045\" style=\"aspect-ratio:1.3350717079530638;width:442px;height:auto\"\/><figcaption class=\"wp-element-caption\">The AML at Kristineberg, Sweden. Credit: EMBL<\/figcaption><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:paragraph -->\n<p>Arriving in Kristineberg just a day or two after the AML, Dudin was excited to be able to finally use the mobile laboratories. \u201cIt's almost like an extension of my own lab,\u201d he said. \u201cThe quality of the equipment is beyond imagining and it\u2019s so well-organised, it just feels like home.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>With the help of the AML, the PlanExM team can collect samples using specially designed \u2018plankton nets\u2019, bring them to the laboratory on wheels, and \u2018fix\u2019 them in three different ways in less than an hour. These methods include using chemical fixatives, high-pressure freezing, and plunge freezing, the latter two allowing researchers to use these samples for electron microscopy. Similarly, for culturing new species, the team is going to be able to combine the speed at which the samples are brought to the mobile lab with the single-cell sorter present on board to potentially get single-cell cultures, something still uncommon in plankton research.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cI think it\u2019s going to change the perspective on how we do certain kinds of research,\u201d said Dudin. \u201cRight now, almost everyone wants to work on model systems because there are clear protocols, images, and tools. And for many of these wild species, no one\u2019s been working on them simply because they are so difficult to catch \u2013 by the time they reach the lab, they are dead. With the AML and with this mission, we are going to keep getting better at collecting data on these understudied organisms and potentially give hope to researchers who want to work on these. In that sense, I think it\u2019s going to be a game changer.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\"><strong>Zooming in on species<\/strong><\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>One of the key challenges in working with environmental samples when compared with model organisms in the laboratory is the sheer heterogeneity \u2013 samples can contain thousands of diverse species and finding the ones you are particularly interested in can be a herculean task.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>The TREC team led by Yannick Schwab, Team Leader and Head of the Electron Microscopy Core Facility at EMBL, is trying to solve this problem. \u201cMy team is interested in developing methods that enable researchers to target electron microscope imaging to specific cells in complex and highly heterogenous specimens,\u201d said Schwab.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>One of the projects Schwab is leading focuses on dinoflagellates, a very rich and diverse group of plankton. When trying to zoom in on specific dinoflagellate groups in environmental samples, researchers need to perform multimodal correlative imaging \u2013 where the same sample is studied via different advanced imaging methods and the results are combined to yield a \u2018big picture\u2019 view. However, to preserve the ultrastructure of these organisms, state-of-the-art cryo-fixation methods are needed, and these sample preparation steps can only be performed with dedicated machines like a high-pressure freezer or a plunge freezer. As Dudin also noted, it\u2019s very unusual for such machines to be available at or near field locations.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cWhen we are collecting non-cultivable dinoflagellates in the field, we need to rush to fix them before they start being denatured. Therefore, we must deploy those instruments for cryo-fixation as close as possible to the sampling; by doing so, we literally freeze our samples on the beach,\u201d said Schwab. \u201cThis would simply not be possible without the AML.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:image {\"id\":64069,\"width\":\"780px\",\"height\":\"auto\",\"aspectRatio\":\"1.6666666666666667\"} -->\n<figure class=\"wp-block-image is-resized\"><img src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/image.png\" alt=\"A composite image of four 3D micrographs showing the cellular organelles of a phytoplankton marked in different colours.\" class=\"wp-image-64069\" style=\"aspect-ratio:1.6666666666666667;width:780px;height:auto\"\/><figcaption class=\"wp-element-caption\">The new vCLEM method reveals ultrastructural details of the phytoplankton <em>Ensiculifera tyrrhenica<\/em>. Shown are the theca (metallic purple), mitochondria (green), chloroplasts (red), nucleus (blue), Golgi complex (yellow), mucocysts (orange) and trichocysts (pink and magenta). Credit: Karel Mocaer and Isabel Romero Calvo\/EMBL<\/figcaption><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:paragraph -->\n<p>In a <a href=\"https:\/\/journals.biologists.com\/jcs\/article\/136\/15\/jcs261355\/325830\/Targeted-volume-correlative-light-and-electron\">recent publication<\/a>, a team led by Schwab and Paolo Ronchi from EMBL Heidelberg <a href=\"https:\/\/www.embl.org\/news\/science\/spotlight-seeing-into-the-seas\/\">demonstrates a new method<\/a> that uses correlative light and electron microscopy to help us accurately identify plankton species collected in the field. The researchers plan to apply this technique to samples from the TREC expedition, with the help of the AML.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\"><strong>Bringing technologies to the field<\/strong><\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:acf\/vfwp-embed {\"name\":\"acf\/vfwp-embed\",\"data\":{\"url\":\"https:\/\/www.youtube.com\/embed\/tSgRkyx-9wM?si=KME-IkxkaDk6T8mU\",\"_url\":\"field_5ecbb005d2d93\",\"caption\":\"\",\"_caption\":\"field_5ecbb0e7d2d94\",\"ratio\":\"16 x 9\",\"_ratio\":\"field_5ecbb0f3d2d95\"},\"mode\":\"preview\"} \/-->\n\n<!-- wp:paragraph -->\n<p>However, as Schwab points out, it is not only the advanced instruments that are important here, but also the dedicated team that enables their use by offering their expertise. In addition to Leisch, the EMBL mobile services team currently includes Michael Bonadonna \u2013 specialist in flow cytometry and cell sorting, Tina Wiegand \u2013 specialist in fluorescence microscopy, and Paulina Cherek \u2013 specialist in electron microscopy sample preparation.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Along with the AML, the mobile services team also helped outfit vehicles that can access different terrains of the sampling sites to support on-site sample collection and a sampling van equipped for sample processing and storage.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Leisch, along with Schwab, Pepperkok, and Paola Bertucci (Head of EMBL Scientific Expeditions), has spent over a year helping develop and deploy the advanced mobile lab, working with the Toutenkamion Group, a French industrial mobility company. \u201cThe process was surprisingly smooth,\u201d said Leisch. \u201cFor every single machine, we came up with a way of making sure we can install it in the truck in such a way that it can be used to its full potential on site, but can also be easily secured during moving. This ensures we can quickly get to work once we arrive at a site. We also brainstormed potential challenges that may arise once on the road and tried to find solutions.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>The process involved many custom-made setups and coordination with multiple scientific instrumentation providers. However, the effort paid off and in August 2023, the AML saw its first full deployment in Kristineberg.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cOn a personal note, it was a great pleasure to work with Franck Neveu and Melanie Asselin from the Toutenkamion Group,\u201d added Leisch. \u201cThe two of them were our contacts on the industry side and halfway through the project, they became as invested as we were in seeing the unit delivered in the best possible way.\"<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:acf\/vfwp-embed {\"name\":\"acf\/vfwp-embed\",\"data\":{\"url\":\"https:\/\/www.youtube.com\/embed\/cq3X3KAOkgY?si=D0laFsaq4CfqEqd1\",\"_url\":\"field_5ecbb005d2d93\",\"caption\":\"\",\"_caption\":\"field_5ecbb0e7d2d94\",\"ratio\":\"16 x 9\",\"_ratio\":\"field_5ecbb0f3d2d95\"},\"mode\":\"preview\"} \/-->\n\n<!-- wp:paragraph -->\n<p>The TREC expedition is going to continue till mid-2024, but AML\u2019s story does not end there. \u201cWe are right now working on making the AML available as a service unit,\u201d said Leisch. \u201cEveryone from individual researchers to consortia or even nations can then ask for and request the services, and then we together with the team would come to provide those on site.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Researchers from EMBL member states agree. \u201cBringing a truck like this on the international scene will allow us to go to places that no one has gone before,\u201d said Dudin. \u201cAnd that opens up possibilities that never existed before.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>In the meantime, the AML will make its way to the next few TREC supersites, where it will continue to inspire intellectual curiosity and collaboration.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong>\u201c<\/strong>One evening, we observed the unicellular organism <em>Noctiluca<\/em> in our samples. Like its name suggests (\u2018Noctiluca\u2019 translates to \u2018light at night\u2019) it is often responsible for the well-known phenomenon of bioluminescence.<em>\u201d<\/em> recalled Leisch. <strong>\u201c<\/strong>Everyone got excited and we set up an impromptu midnight sampling in order to collect more of these microbes in the night. It was past midnight and the whole place was buzzing with enthusiasm and excitement and scientific curiosity. And it was just so beautiful to see that and be able to experience that with my colleagues.\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:acf\/vfwp-card {\"name\":\"acf\/vfwp-card\",\"data\":{\"image_source\":\"media_library\",\"_image_source\":\"field_602ba83883d48\",\"image\":\"\",\"_image\":\"field_5ebd3243ee8ec\",\"title\":\"\",\"_title\":\"field_5ebd3243ee989\",\"subheading\":\"\",\"_subheading\":\"field_603b4403d386e\",\"text\":\"EMBL acknowledges the generous support of many institutions, donors and sponsors, in particular the Manfred Lautenschl\u00e4ger Foundation, as well as Eppendorf SE, and Carl Zeiss Microscopy, in helping make the AML possible. We also thank Thermo Fisher Scientific and Ted Pella, Inc. for donating scientific instruments for the AML.\",\"_text\":\"field_5ebd3243eea26\",\"link\":\"\",\"_link\":\"field_5ebd3243eeac3\",\"style\":\"striped\",\"_style\":\"field_5ebd3244102b1\",\"image_ratio\":\"default\",\"_image_ratio\":\"field_61d41d4bcbbee\"},\"mode\":\"preview\"} \/-->","post_title":"Taking science on the road","post_excerpt":"With the new advanced mobile laboratory, EMBL is taking its service offerings to new heights, bringing cutting-edge life science technologies to the field in a way never seen before. ","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"taking-science-on-the-road","to_ping":"","pinged":"","post_modified":"2023-11-15 10:02:50","post_modified_gmt":"2023-11-15 09:02:50","post_content_filtered":"","post_parent":0,"guid":"https:\/\/www.embl.org\/news\/?post_type=embletc&#038;p=64003","menu_order":0,"post_type":"embletc","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":64005,"post_author":"16","post_date":"2023-11-15 10:00:00","post_date_gmt":"2023-11-15 09:00:00","post_content":"<!-- wp:paragraph -->\n<p><em>By Maria Papanikolaou and Anna Stanescu, EMBL<\/em><\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Although the idea of a European laboratory for life sciences was conceived in 1962, it would take 11 more years, involving conversations between Nobel prize winners, an unusual endorsement from two female UK government officials, and the signatures of 10 member state officials, to authorise the concept.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>\u201cThere was resistance at the Royal Society, but persuading governments was the biggest problem. A lot of people felt that it was hopeless,\u201d said Sir John Kendrew, EMBL's first Director General and Nobel Prize-winning structural biologist <a href=\"https:\/\/archive.embl.org\/uploads\/r\/archive-of-european-molecular-biology-laboratory\/5\/2\/7\/527f5bacfba61700710e3872918b270ac75a07ab1f7dcac8ee629522006c67cb\/DE_2324_C-PUBS-A-20.pdf\">in a 1994 interview<\/a>. \u201cIn the end, the British political support came from two women, Shirley Williams and Margaret Thatcher who were both ministers in the Department of Education and Science in successive British governments. Long before she became Prime Minister, Margaret Thatcher had read chemistry at Oxford\u2026as the new Conservative Secretary of State for Education and Science, she apparently took the EMBL file home one weekend \u2013 it was about a foot thick \u2013 and came back on Monday morning and said, \u2018We join!\u2019\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:image {\"align\":\"right\",\"id\":64093,\"width\":\"437px\",\"height\":\"auto\",\"aspectRatio\":\"1.3365921787709498\"} -->\n<figure class=\"wp-block-image alignright is-resized\"><img src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/image-1.png\" alt=\"\" class=\"wp-image-64093\" style=\"aspect-ratio:1.3365921787709498;width:437px;height:auto\"\/><figcaption class=\"wp-element-caption\">Photo: EMBL Archive, Grenoble Anniversary material (unprocessed collection)&nbsp;<\/figcaption><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:paragraph -->\n<p>The idea for the creation of a European molecular biology laboratory was first proposed when two Nobel Prize-winning biologists, Kendrew and <a href=\"https:\/\/en.wikipedia.org\/wiki\/James_Watson\">James Watson<\/a>, met with<a href=\"https:\/\/en.wikipedia.org\/wiki\/Leo_Szilard\"> Leo Szilard<\/a> \u2013 Hungarian-German-American physicist and inventor \u2013&nbsp; and the Director General of CERN <a href=\"https:\/\/en.wikipedia.org\/wiki\/Victor_Weisskopf\">Victor Weisskopf<\/a> at CERN in Geneva in December 1962.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>In 1964, the <a href=\"https:\/\/www.embo.org\/\">European Molecular Biology Organization (EMBO)<\/a> was founded, followed by the establishment of the <a href=\"https:\/\/embc.embo.org\/about-embc\/\">European Molecular Biology Conference<\/a> (EMBC) in 1970. Prolonged discussions followed, allaying the concerns of the national governments \u2013 member states of the EMBC \u2013 that a central laboratory might <a href=\"https:\/\/www.embl.org\/documents\/wp-content\/uploads\/2023\/09\/40-years-embl-magazine.pdf\">\u201cdraw away <\/a>their country\u2019s best scientists\u201d<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>In 1971, the EMBC took significant steps towards the creation and growth of the laboratory. They did so by forming four working groups, in cooperation with EMBO, to guide the establishment process. These efforts were overseen by a Steering Committee, and as a result of these collaborative endeavours, a draft agreement outlining the establishment of the laboratory was prepared (EMBC, Annual Report April 1971, <a href=\"https:\/\/archive.embl.org\/europ-conference-on-m-b\">Kenneth Holmes material<\/a>, EMBL Archive).<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><a href=\"https:\/\/archive.embl.org\/embo-allgemeine-mitteilungen\">Between 1972 and 1973<\/a> the EMBL Agreement was ready to be signed by ten out of the thirteen member states of the EMBC. On April 12, 1973, the EMBL Secretary-General announced to the EMBO members the date and location of the EMBL Signing Agreement Ceremony, pointing out that \u201cthe Agreement will take legal effect when a sufficient number of the Governments have ratified the representatives\u2019 signatures \u2013 a process that is estimated to require about one year\u201d.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>The pivotal moment in the establishment of EMBL was the signing of the <a href=\"https:\/\/archive.embl.org\/uploads\/r\/archive-of-european-molecular-biology-laboratory\/3\/3\/9\/33933be653199adc40e6b9cf5ef0bf96855c0dae0234ed8e68444168a9c40d23\/DE_2324_SEC-A-1.pdf\">EMBL Agreement<\/a> on May 10, 1973, followed by its ratification in July 1974.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:image {\"align\":\"right\",\"id\":64095,\"width\":\"572px\",\"height\":\"auto\",\"aspectRatio\":\"1.3194444444444444\"} -->\n<figure class=\"wp-block-image alignright is-resized\"><img src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/image-2.png\" alt=\"\" class=\"wp-image-64095\" style=\"aspect-ratio:1.3194444444444444;width:572px;height:auto\"\/><figcaption class=\"wp-element-caption\">Photo: EMBL Archive, Grenoble Anniversary material (unprocessed collection)&nbsp;<\/figcaption><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:paragraph -->\n<p>The agreement signing ceremony took place at CERN in Geneva on the 10th of May 1973, where the document was signed by representatives of ten of EMBC member states \u2013 <a href=\"https:\/\/de.wikipedia.org\/wiki\/Josef_L%C3%B6ns\">Josef L\u00f6ns<\/a> for the Federal Republic of Germany, <a href=\"https:\/\/en.wikipedia.org\/wiki\/Frederick_Mason_(diplomat)\">Frederick Mason<\/a> for the United Kingdom of Great Britain and Northern Ireland, Erik Thrane for Denmark, <a href=\"https:\/\/de.wikipedia.org\/wiki\/Emanuel_Treu\">Rudolf Martins <\/a>for Austria, Bernard Dufournier for France, <a href=\"https:\/\/en.wikipedia.org\/wiki\/Shabtai_Rosenne\">Shabtai Rosenne<\/a> for Israel, <a href=\"https:\/\/de.wikipedia.org\/wiki\/Ren%C3%A9_Keller_(Diplomat)\">Rene Keller<\/a> for Switzerland, Polak Rosenberg for the Netherlands, Smoquina from Italy, and Rune Fremlin from Sweden.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>The EMBL Signing Agreement Ceremony was a significant event attended by prominent figures from the worlds of science and politics who had played pivotal roles in the establishment of EMBL.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:image {\"align\":\"left\",\"id\":64097,\"width\":\"410px\",\"height\":\"auto\",\"aspectRatio\":\"0.7578323454699407\"} -->\n<figure class=\"wp-block-image alignleft is-resized\"><img src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/image-3.png\" alt=\"\" class=\"wp-image-64097\" style=\"aspect-ratio:0.7578323454699407;width:410px;height:auto\"\/><figcaption class=\"wp-element-caption\">Photo: <a href=\"https:\/\/archive.embl.org\/frieda-glockner-material\">Frieda Gl\u00f6ckner material<\/a>, EMBL Archive&nbsp;<\/figcaption><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:paragraph -->\n<p>Among the distinguished participants were: <a href=\"https:\/\/en.wikipedia.org\/wiki\/Fran%C3%A7ois_Jacob\">Fran\u00e7ois Jacob<\/a>, a renowned French biologist and Nobel Prize laureate, <a href=\"https:\/\/cordis.europa.eu\/article\/id\/13161-prof-paolo-fasella-19301999\">Paolo Fasella<\/a>, the Director General of the European Commission's Directorate General for Science, <a href=\"https:\/\/100jahre.ggh-heidelberg.de\/geschichten\/geschichte\/erster-buergermeister-dr-karl-korz\">Karl Korz<\/a>, the First Mayor of Heidelberg (Baub\u00fcrgermeister), <a href=\"https:\/\/prabook.com\/web\/raymond.appleyard\/1297824\">Raymond Appleyard<\/a>, the Executive Director of EMBO, <a href=\"https:\/\/en.wikipedia.org\/wiki\/Willibald_Jentschke\">Willibald Jentschke<\/a>, the Director General of CERN (the European Organization for Nuclear Research), H. Voirier, the president of EMBC,&nbsp; and <a href=\"https:\/\/en.wikipedia.org\/wiki\/Jeffries_Wyman_(biologist)\">Jeffries Wyman<\/a>, who served as the Chairman of the Steering Committee responsible for the establishment of EMBL, and was also the first Secretary General of EMBO and professor at the University of Rome.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>These individuals came together to mark the historic occasion of the EMBL Signing Agreement Ceremony, symbolising the culmination of dedicated efforts to bring this vital scientific institution into existence.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>The EMBL Agreement officially became effective on July 4 1974, coinciding with the day when most of the signatory states had ratified, approved, and accepted the agreement, in accordance with <a href=\"https:\/\/www.embl.org\/documents\/wp-content\/uploads\/2020\/05\/un_agreement.pdf\">its Article XV<\/a>. Notably, France's participation in the ratification process at this stage was pivotal in bringing the agreement into force on this date.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>In 2024, EMBL will celebrate its fiftieth anniversary. The occasion not only offers us an opportunity to share stories from past achievements but more importantly, provides us a reminder to keep moving forward to pursue tough scientific questions, pushing forward the frontiers of molecular biology and further integrating with other disciplines to have real-world impact. We hope you will join us in celebrating and reflecting on EMBL\u2019s tradition of pushing the envelope of scientific possibility as well as leading European life sciences to new heights.<\/p>\n<!-- \/wp:paragraph -->","post_title":"Remembering the moment EMBL was established","post_excerpt":"The EMBL agreement, which made reality the idea of creating a European laboratory for life sciences, was signed in 1973 and ratified in 1974. Fifty years later, we look back at this historic moment.","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"remembering-the-moment-embl-was-established","to_ping":"","pinged":"","post_modified":"2023-11-15 10:17:54","post_modified_gmt":"2023-11-15 09:17:54","post_content_filtered":"","post_parent":0,"guid":"https:\/\/www.embl.org\/news\/?post_type=embletc&#038;p=64005","menu_order":0,"post_type":"embletc","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":64007,"post_author":"16","post_date":"2023-11-15 13:00:00","post_date_gmt":"2023-11-15 12:00:00","post_content":"<!-- wp:paragraph -->\n<p><em>By Sara Fahs,<\/em> <em>Associate Director, BioNTech<\/em> <em>SE<\/em><\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>My curiosity about the origins of everyday things, like how medicines are made or why some cultures are extremely different from others, can be traced back to my childhood. My early years were also marked by diverse interests, including acting, interior architecture, philosophy, sociology, and understanding human connections. My journey in science has thus been remarkable, transitioning from a high school background in literature and philosophy to the natural sciences in college. My ambitions led me to a career in academia and industry, which I now reflect upon with pride.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Towards the start of this career, my initial decision to pursue a medical career in Lebanon gradually evolved into a fascination with drug design and medicinal chemistry. I narrowed down my research interests to medicinal chemistry during my MSc in the UK. My journey took a unique turn with a PhD fellowship at EMBL, a special but challenging experience given my background in organic chemistry.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>My move to EMBL posed a multitude of new layers to adapt to, including completely new cultures; new technologies, scientific disciplines, and concepts; and working in a field where generating extensive data quickly was impossible. Despite the challenges, I learned to focus on my learning path and avoid comparisons, even when surrounded by the \"buzz of abundance\", all the while expanding my technical and theoretical knowledge.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:image {\"align\":\"right\",\"id\":64113,\"width\":\"336px\",\"height\":\"auto\",\"aspectRatio\":\"0.966796875\",\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image alignright size-large is-resized\"><img src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/P88A6043-Kopie-990x1024.jpg\" alt=\"\" class=\"wp-image-64113\" style=\"aspect-ratio:0.966796875;width:336px;height:auto\"\/><figcaption class=\"wp-element-caption\">Sara Fahs during her time at EMBL. Credit: Photolab\/EMBL<\/figcaption><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:paragraph -->\n<p>During my time at EMBL, I had the privilege of working with key mentors. I was lucky to work with Maja K\u00f6hn, who introduced me to the power of interdisciplinarity. Prof. K\u00f6hn's brilliant science and leadership skills, along with her determination and ambition, inspired me to seek answers using many tools. Additionally, I was mentored by David Will, who then headed the medicinal chemistry lab at the chemical biology core facility in EMBL. David's deep intellect, wide insights, and rich experience in both academia and industry, in addition to the inspiring industry-standard MedChem Lab he helped build at EMBL, provided me with valuable insights into the bigger picture.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>In light of this \u201ccriss-cross\u201d approach to growing knowledge and skills in scientific theory, practice, and ideas, my journey was distinguished by an absence of long-term, strict, and explicit goals, but a deep appreciation for, and delight in, the short-term ones. At the same time, I kept crafting a specialisation in the field I was passionate about \u2013 medicinal chemistry.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\"><strong>Why the world needs generalists<\/strong><\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Originally specialised as a chemist, I found fulfilment in embracing a generalist approach to science. I strongly believe being spontaneous and open to different subjects has expanded my creativity. While specialisation is essential, building a range of skills and knowledge areas enhances problem-solving abilities. For instance, in my career, whenever a research problem needed to be addressed via a different discipline, I would not hesitate to research that discipline and then contact the right people.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Some problems need generalists, some problems need specialists, and we must be open to both and know when to assign which of the two for a task. This way, I think we could avoid a lot of time and resources being wasted. In fact,\u00a0in today's highly complex world, developing a palette of assorted experience across many fields is perhaps more pertinent than (hyper)specialisation. The perpetually troublesome challenges\u00a0of today (be it financial, geological, computational etc.) necessitate associating skills and expertise from various domains to promote solutions.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\"><strong>Research careers in industry: myths and opportunities<\/strong><\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>I joined the company BioNTech after my PhD, a move motivated not only by my desire to apply my skills in a translational medicinal chemistry role but also by the need to be quick in finding a new position. Back then, I was still on a limited visa and did not have time to find the perfect academic position (or roam the world for a gap year). I was also unsure whether I wished to remain in academia. Within a few months, I wrote my research paper, wrote my thesis, defended it, applied for jobs, all the while taking care of bureaucratic chores. Hence, I didn\u2019t have much time or mind space for the common fears that some may have about switching to industry.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>The most common fear I heard about during that time is permanent project instability. Projects in industry do change, which is sometimes sad, especially when one has developed an attachment to it. But the charming thing about changing projects is the transferability of skills and experiences into the next. And this is beneficial in the long term, as one only gets better and more efficient with time. Also, projects do not change <em>that<\/em> fast. The lifetime of a project can be prolonged as long as its efficacy remains promising.\u00a0And this makes sense.<br>On the positive side, the possibility of bringing an academic flair to industry while enjoying a different setting and staying scientifically curious can really act in one\u2019s best interest. Not to mention the amount of space that regular\/flexible working hours can make so one can grow other interests and\/or work on extracurricular projects. This especially benefits me who, as a generalist, constantly needs time and energy for pursuing multiple avenues, especially in an increasingly complex and intersected world.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>I would stress, however, the challenges of finding a position that combines translational medicinal chemistry with an academic touch and emphasise the need for improved job positions and networks in this context.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>During my time at BioNTech, I have transitioned from postdoc to staff scientist, to team leader, to Associate Director in medicinal chemistry, while witnessing the company\u2019s own transition from private to public. While participating in multiple projects across departments and sites, I could see first-hand how it had to grow its own structural foundations to match its rapid growth. I am lucky to have had this medium to mature.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\"><strong>Pushing the frontiers of medicinal chemistry<\/strong><\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>\u201cI have been involved in multiple research projects over the last several years, which illustrate both the interdisciplinary and generalist approaches to science I like to advocate for. The first of these was a discovery project, which aimed, in the long run, to make cancer cells more sensitive to the immune system, and eventually less resistant to therapy. This discovery project grew by\u00a0imbuing a classical medicinal chemistry project with interdisciplinarity (using technologies like proteomics, sequencing, novel in vitro assays, and others). From a small local project, this grew into to a larger collaborative one, and I have found that diverse perspectives always make more impact.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>A second project aimed to make delivery of anticancer drugs and immunomodulators more specific. It involved various fields of chemistry and life sciences. Due to my experience, I could serve, in the words of a colleague, as \u201cthe glue that bound together scientists\u201d from different fields. As a \u201cscientific translator\u201d in this project, who brought together experimental biologists and computational scientists, I grew a lot, learned about many techniques, and could contribute better.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Afterwards, I worked on lipid carrier systems for mRNA delivery in vaccines, a project that required further use of my adaptability and expanding specialisation and helped me contribute to scientific improvements. Now I am creating my own project, combining years of varied experience and knowledge as a driving force. This is very exciting, especially as it also pursues a long-standing research interest.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Chemistry was a driver in all those projects and endeavours, and I saw chemistry being tailored to apply differently to each problem, with subfields such as peptide chemistry, small molecule chemistry, lipid chemistry, probes, dyes, etc. coming into play in various ways. It is very interesting to study the therapeutic potential of small molecules. &nbsp;After all, to quote a friend, chemistry can also help \u201cmake therapeutic molecules that have never been made in the history of the universe\u201d. In the light of this, I am happy to push chemistry further in today\u2019s biotech environments.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>I have also grown people management skills in science throughout this whole journey and would love to grow them even further. It is the soft skill which most enhances meaningful conversations and learning from one another. And throughout the journey, my EMBL heritage and curiosity has helped me embrace new challenges and come up with new perspectives and ways of approaching scientific problems.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\"><strong>Art, science, and beyond<\/strong><\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>My passion for connecting art and science is evident in my involvement in music production, theatre, DJ'ing, writing, and science communication, even during my days at EMBL. I have always highlighted the importance of keeping my inner artist alive, as creativity can be a valuable outlet for both emotions and innovative thinking. Also, I never knew this was a \u201cpassion\u201d, until I observed my patterns and decisions retrospectively after almost fifteen years of working in science. My point is that a passion, or whatever you would like to call it, doesn\u2019t have to be pre-determined; it can be discovered, and at one\u2019s own rhythm.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Finally<strong>, <\/strong>I would like to emphasise the importance of regular drive, courage, and perseverance in the scientific journey. I advise future scientists to reclaim their attention spans (it has been stolen from us in this world of hyper information and exposure) and advocate for diversity of backgrounds, personalities, and thinking patterns. I advise making general interest a habit when listening to a peer, instead of competition. It teaches us much more. And I believe that genuine openness to different ideas and perspectives, coupled with trusting one\u2019s process of development (background, experiences, lessons, hardship etc.) but at the same time questioning one\u2019s own narratives, is crucial for growth and success.<\/p>\n<!-- \/wp:paragraph -->","post_title":"Advocating for a generalist approach to science and life","post_excerpt":"Sara Fahs, who did her PhD from EMBL Heidelberg and is one of the newest members of the EMBL alumni association board, writes about key insights from her journey in science and her work on medicinal chemistry, during a career spanning academia and industry.","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"advocating-for-a-generalist-approach-to-science-and-life","to_ping":"","pinged":"","post_modified":"2023-11-16 10:26:34","post_modified_gmt":"2023-11-16 09:26:34","post_content_filtered":"","post_parent":0,"guid":"https:\/\/www.embl.org\/news\/?post_type=embletc&#038;p=64007","menu_order":0,"post_type":"embletc","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":64009,"post_author":"124","post_date":"2023-11-15 10:00:00","post_date_gmt":"2023-11-15 09:00:00","post_content":"<!-- wp:paragraph -->\n<p>Baubak Bajoghli\u2019s interest in microscopy began at an early age and helped him keep expanding his horizons in biological research. In a career spanning both fundamental and translational research, Bajoghli has kept his passion for imaging alive and has recently taken up a role as the Director of Austrian Bioimaging\/CMI, where he works to improve access to advanced microscopy infrastructure for researchers working across the country.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>We caught up with Bajoghli about his research on cancer-linked immune cells, his key takeaways from his time at EMBL, and the importance of improving access to research infrastructures across Europe.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3 class=\"wp-block-heading\"><strong>What triggered the start of your journey in science?<\/strong><\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Well, my interest in microscopy began when I was 14 and I visited a medical laboratory for diagnostics for a high school project. My father bought me a microscope, and I had a lot of fun counting all types of white blood cells, including neutrophils and lymphocytes, in patients' blood smears and comparing my results with those of the laboratory staff. One thing led to another, and my endless curiosity developed into a passion for science.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3 class=\"wp-block-heading\"><strong>Can you tell us about your work at EMBL, and how it has influenced your journey as a researcher?<\/strong><\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>It has consistently influenced my path over the last 20 years. It began when I did an internship during my undergraduate years at Jochen Wittbrodt's lab in the Developmental Biology Unit, where I learned about using medaka fish as a model organism and transgenesis methods. After a month, I returned to Vienna with 300 medaka eggs in my baggage and, with help from Jochen, my former supervisor, Thomas Czerny, we set up Austria's first medaka research facility in 2002.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>After my post-doctoral fellowship at the Max-Planck Institute of Immunobiology, I became fascinated by the development of T-cells, which belong to our adaptive immune system. The process involves two migratory journeys. First, T-cell progenitors originating from the hematopoietic tissue in the bone marrow must migrate through the body and find the thymus organ. Second, within the thymus, these progenitors have to follow a precise migratory path within different microenvironments, to develop as naive T-cells before they leave the organ.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:image {\"align\":\"right\",\"id\":64081,\"width\":\"466px\",\"height\":\"auto\",\"aspectRatio\":\"1.2503052503052503\",\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image alignright size-large is-resized\"><img src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/Medaka-thymus-1024x819.jpg\" alt=\"Microscopy image shhowing a transgenic Medaka fish larva, with cells marked in green or red and the thymus showing up as a bright yellow circle. \" class=\"wp-image-64081\" style=\"aspect-ratio:1.2503052503052503;width:466px;height:auto\"\/><figcaption class=\"wp-element-caption\">Transgenic medaka larvae can be utilised to investigate T-cell trafficking within the thymus (marked in yellow) and throughout the entire body. Credit: Baubak Bajoghli<\/figcaption><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:paragraph -->\n<p>At that time, our knowledge relied mostly on histological sections, and how developing T-cells sense different environments and control their migratory behaviour was less understood. Being skilled in generating transgenic medaka fish, I decided to employ live imaging of the thymus in this species, because imaging of the mouse thymus is <a href=\"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2018.00375\/full\">technically not possible<\/a>.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>From my time as an intern, I knew that EMBL's Advanced Light Microscopy Facility (ALMF) was the right place to test this feasibility. In 2012, I joined Maria Leptin's lab as an EIPOD fellow to pursue my scientific dream and visualised the migratory behaviour of all developing T-cells within an organism using different imaging technologies. The data we generated over five years at EMBL became the foundation of many studies when I became a principal investigator (PI) at the University Hospital T\u00fcbingen.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3 class=\"wp-block-heading\"><strong>Can you tell us a bit more about your research on immune cells and cancer at the University Hospital T\u00fcbingen?<\/strong><\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>My team focused on two different research topics. First, we continued our work on the T-cell development that began at EMBL. We extracted quantitative data from our <em>in vivo<\/em> imaging experiments and, for the first time, developed a virtual thymus organ in collaboration with Erika Tsingos. By combining cell-based computer modelling and <em>in vivo<\/em> manipulation of the thymic niche, we uncovered how the interaction between cell location, signals from the thymic niche, and the timing of gene expression affects the fate decision of progenitor cells in the thymus.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:image {\"id\":64083,\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/PC-model-1024x421.jpg\" alt=\"Computer generated models showing cells as overlapping circles, marked in various colours according to their types. \" class=\"wp-image-64083\"\/><figcaption class=\"wp-element-caption\">The 'virtual thymus' is a cell-based computational model created to assess the impact of parameters for cell migration (top-left), cell division (top-right), and various signals from the niche (bottom) on both normal and malignant T-cell development. This model, for the first time, allows scientists to predict the results of a scenario before conducting an animal experiment. Credit: Baubak Bajoghli. <\/figcaption><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:paragraph -->\n<p>Furthermore, we enhanced our virtual thymus model to investigate the causes of T-cell lymphoblastic leukaemia (T-ALL), which is still a long-standing mystery. Through computational simulations of over 300 scenarios, we pinpointed the minimum requirements for the clonal expansion of a single developing T-cell \u2013 a process wherein immune cells divide quickly to give rise to many clones \u2013 which we confirmed experimentally. The strategy that we have developed not only provided us with a rapid and comprehensive overview of the outcomes in all scenarios but also helped in reducing the need for animal experiments, thus implementing the principles of the 3Rs (reduce, reuse, recycle) in science. Currently, we are finalising the data analysis and preparing to draft a research manuscript outlining our findings.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:image {\"align\":\"right\",\"id\":64079,\"width\":\"281px\",\"height\":\"auto\",\"aspectRatio\":\"0.928\",\"sizeSlug\":\"full\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image alignright size-full is-resized\"><img src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/T-ALL-thymus_1_2021-04-09T16-58-33.240.jpg\" alt=\"Microscopy image showing T-cell progenitor cells in green and thymic niche cells in blue.\" class=\"wp-image-64079\" style=\"aspect-ratio:0.928;width:281px;height:auto\"\/><figcaption class=\"wp-element-caption\">Malignant T-cell progenitor cells (green) proliferate within the thymus and also exert an impact on the growth of the thymic niche cells (blue). Credit: Baubak Bajoghli. <\/figcaption><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:paragraph -->\n<p>The focus of the translational oncology division, where I was hosted, was to find new ways to treat congenital neutropenia, a rare blood disorder that affects patients, mostly young children, causing extremely low levels of neutrophils (a type of white blood cell) in their blood. Consequently, these patients are highly susceptible to bacterial infections, and today, their only treatment option is a daily injection of a cytokine for their entire lives, which unfortunately increases their risk of developing leukaemia by 20%. Therefore, my team strongly contributed to collaborative projects which helped to better understand the underlying mechanisms. We developed various zebrafish models for congenital neutropenia. Also, we established new patient-derived xenotransplantation models (systems where patients\u2019 samples are implanted into a model organism like zebrafish or mice) to test the effectiveness of various small molecules against the proliferation of leukemic cells.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3 class=\"wp-block-heading\"><strong>Your work has spanned both basic and translational aspects. Could you tell us a bit about the connections between the two and your experience working across both worlds?<\/strong><\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>After 15 years of working in basic research, moving to translational research was a big transition in my scientific career. You need to adjust your mindset because, as you said, these are two different worlds. Before, I was used to asking fundamental questions about how biological processes work. When I became a PI in the translational oncology division, my main focus shifted towards developing new tools for preventing or treating diseases.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>I quickly realised that success in applied research relies heavily on a solid foundation of basic research. Even something as seemingly distant as understanding the evolution of genes can be incredibly helpful in designing new tools for fighting human diseases.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Take the gene called <em>ELANE<\/em>, for example. About 45% of patients with congenital neutropenia have missense mutations in this gene. When I explored the evolution of this gene and used the ENSEMBL database, I noticed that <em>ELANE<\/em> is a product of tandem gene duplication that occurred in the mammalian lineage, and lower vertebrates don\u2019t have this gene.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Because I knew from previous studies published by other colleagues that the development of neutrophils is evolutionarily conserved across vertebrates, I made the case to medical scientists that if fish can develop neutrophils without <em>ELANE<\/em>, then maybe this gene isn't as crucial for human neutrophil development as we once thought. And it turned out to be true. When they knocked out the dysfunctional <em>ELANE<\/em> gene in induced-pluripotent stem (iPS) cells derived from patients, they were able to develop as neutrophils normally.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Now, ongoing work at the University Hospital T\u00fcbingen is focused on establishing this as a new therapeutic approach for these patients. It's a great example of how basic research can lead to practical solutions in the field of medicine. Unfortunately, basic research often doesn't get the recognition it deserves from funding bodies and the public, but it needs to be properly appreciated.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3 class=\"wp-block-heading\"><strong>You are currently the Director of Austrian Bioimaging\/CMI. Can you tell us what motivated this transition?<\/strong><\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Again, my passion for imaging and my personal experiences as a researcher played a significant role in my decision to make a huge transition in my career path, this time from a researcher to a research infrastructure provider. When I started my own lab, my host institute had promised me access to the necessary microscopes for my fully funded thymus project. However, the reality didn't match the promise, and I had to invest a lot of time into figuring out which institutes had the right microscopes and whether my team could use them.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>It was frustrating because we could not use the imaging facilities of other institutes due to legal policies. In the end, with Maria Leptin\u2019s support, we could fortunately use the Advanced Light Microscopy Facility (ALMF) at EMBL. For almost two years, multiple times a month, I drove 180 kilometres from T\u00fcbingen to Heidelberg in the morning, performed imaging at the ALMF, and then drove back home in the afternoon.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>It was challenging, but I was grateful because, without access to the right microscope, we could not have answered a 30-year-old question about how some species, despite using the same molecular mechanism and the same progenitor cells, <a href=\"https:\/\/www.science.org\/doi\/10.1126\/sciadv.abg3613?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%20%200pubmed\">develop a higher frequency<\/a> of certain T-cell sublineages compared to others. In the long term, this discovery might help in the development of new therapeutic applications, as some T-cell sublineages have antitumour functions, yet their proportion in the human body is less than 1%.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>My own experiences have made me acutely aware that many scientists have outstanding research projects but struggle to conduct experiments properly due to a lack of equipment, expertise, or resources at their host institutions. On the other hand, I understand that it's not economically feasible for institutions to invest in every expensive instrument their employees might temporarily need. In my opinion, the most effective solution to this problem is taking advantage of pan-European consortia of research infrastructures that offer access to cutting-edge technologies for all researchers, regardless of their institutional affiliations.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3 class=\"wp-block-heading\"><strong>Can you tell us a bit more about Austrian BioImaging\/CMI and how consortia like these can help researchers?<\/strong><\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Austrian BioImaging\/CMI is one such consortium at the national level, consisting of eight Austrian universities and leading research institutions. We enable researchers to access over 40 imaging technologies for biological and preclinical research, and as a node, we strongly cooperate with Euro-BioImaging, which is a European Research Infrastructure Consortium (ERIC) member.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:image {\"align\":\"left\",\"id\":64077,\"width\":\"503px\",\"height\":\"auto\",\"aspectRatio\":\"1.499267935578331\",\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image alignleft size-large is-resized\"><img src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/Baubak-Bajoghli-1-1024x683.jpg\" alt=\"\" class=\"wp-image-64077\" style=\"aspect-ratio:1.499267935578331;width:503px;height:auto\"\/><figcaption class=\"wp-element-caption\">Baubak Bajoghli at the EMBL Imaging Centre, Heidelberg. Credit: Massimo del Prete\/EMBL<\/figcaption><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:paragraph -->\n<p>During my 18 months in office, I've been committed to ensuring that researchers don't face the same challenges I did. To me, open access to research infrastructures should be a pillar of open science in European policy. I don\u2019t tire of communicating with researchers, heads of universities and funding bodies, and Austrian policymakers to raise their awareness about the key role of state-of-the-art research infrastructures in generating knowledge breakthroughs and new discoveries, and why their sustainability is so important. I'm appears that the European Commission also recognises their importance.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Currently, there are several Horizon Europe programs that financially support researchers\u2019 access to high-quality resources, including biological and biomedical imaging technologies. I really recommend that researchers always keep themselves well-informed so that they can make the maximum use of the available resources for their projects. Since there are numerous options available, Austrian Bioimaging\/CMI and Euro-Bioimaging also provide consulting services for researchers.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3 class=\"wp-block-heading\"><strong>In your opinion, how do initiatives like Euro-Bioimaging and Austrian Bioimaging influence the way biological research is done in European countries (and globally)?<\/strong><\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>To strengthen our competitiveness in global research, specific attention should be given to national and European research infrastructures consortia. To me, their socio-economic impact is unquestionably high. In today's rapidly evolving technological landscape, access to cutting-edge technologies and services is crucial for performing outstanding research. However, building and maintaining cutting-edge research infrastructures can be expensive and by sharing these costs, individual institutes and countries can reduce the financial burden, making research more economically sustainable in Europe.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Additionally, European research infrastructure consortia such as Euro-BioImaging have the potential to act as incubators for innovation and technology transfer. In Austrian BioImaging\/CMI, 40% of our technology units consist of research groups specialising in various imaging modalities, and developing tools for biological research or medical diagnostics.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>It's important to note that we are just one of 35 nodes within Euro-BioImaging. So, there is a huge potential for cooperation between 173 imaging facilities and research groups from 16 countries and EMBL associated with Euro-BioImaging, as well as with the private sector, to drive innovation and address future research needs. Solutions for open bioimaging data, common standards and best practices for biological and medical imaging can only be achieved at the pan-European level.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Last but not least, research infrastructure consortia must cooperate to enhance their visibility because we can only attract top talent when we can provide access to cutting-edge research infrastructures in Europe, which in the long run, will also bring financial benefits.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3 class=\"wp-block-heading\"><strong>What is one piece of advice you would give to young researchers just starting their scientific journeys?<\/strong><\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>Find something that is your passion and dedicate your life to it.<\/p>\n<!-- \/wp:paragraph -->","post_title":"Impact of access to imaging technologies on scientific achievements","post_excerpt":"Baubak Bajoghli, Director of Austrian Bioimaging\/CMI, discusses his passion for imaging and his work straddling basic and applied research in biology.","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"impact-of-access-to-imaging-technologies-on-scientific-achievements","to_ping":"","pinged":"","post_modified":"2023-11-15 10:17:17","post_modified_gmt":"2023-11-15 09:17:17","post_content_filtered":"","post_parent":0,"guid":"https:\/\/www.embl.org\/news\/?post_type=embletc&#038;p=64009","menu_order":0,"post_type":"embletc","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":64101,"post_author":"120","post_date":"2023-11-15 10:00:00","post_date_gmt":"2023-11-15 09:00:00","post_content":"<!-- wp:paragraph -->\n<p>Three EMBL predocs,<strong> Constantin Ahlmann-Eltze<\/strong> in the Huber Group at EMBL Heidelberg, <strong>Charlie Barker<\/strong> in the Petsalaki Group at EMBL-EBI, and <strong>Sora Matsumoto <\/strong>in the Saka Group at EMBL Heidelberg were invited to participate in the <a href=\"https:\/\/twitter.com\/embl\/status\/1672231050905354242\">72nd Lindau Nobel Laureate Meeting <\/a>in June 2023. Joining them wereare two alumni, <strong>Vlad Bondarenko<\/strong>, Predoctoral Fellow in the former Hiiragi Group and <strong>Jonas Tholen, <\/strong>Postdoctoral Fellow of the Galej Group, who were accepted to the conference when still at EMBL. Once every year, Nobel Laureates convene in Lindau to meet the next generation of leading scientists all over the world, for an exchange of knowledge, ideas, and experience. The young scientists remain permanent members of the Lindau Alumni Network and ambassadors for scientific dialogue.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong>Constantin Ahlmann-Eltze<\/strong>, Predoctoral Fellow in the Huber Group at EMBL Heidelberg<strong>, <\/strong>and <strong>Simone Bell<\/strong>, Senior Project Manager in the Huber Group, have each received a <a href=\"https:\/\/bioconductor.org\/about\/awards\/#:~:text=Bioconductor%20Community%20Awards,of%20the%20criteria%20listed%20below.\">Bioconductor Community Award<\/a> from the Bioconductor Project. The project aims to develop, support, and disseminate free open-source software that facilitates rigorous and reproducible analysis of data from biological assays. Four awardees are selected each year to honour outstanding contributions to the project.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong>Silvia Colucci<\/strong>, currently a postdoc in the Hentze Group and former PhD student in the Muckenthaler\/Hentze MMPU group, has been awarded the <a href=\"https:\/\/www.uni-heidelberg.de\/de\/newsroom\/auszeichnungen-fuer-junge-heidelberger-wissenschaftler-0\">Ruprecht-Karls-Preis for the faculty of Bioscience at Heidelberg University<\/a> for her PhD thesis in 2022. Given by the Heidelberg University Foundation, this award recognises exceptional scientific work from all subject areas and honours five dissertations each year.\u00a0<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong>Mohannad Dardiry<\/strong>, Postdoctoral Fellow in the Ikmi Group at EMBL Heidelberg, has been awarded the <a href=\"https:\/\/www.teufel-stiftung.de\/biologie\/\">PhD prize of the Reinhold and Maria Teufel Foundation<\/a>. To support the development of budding young scientists, the prize recognises top achievements in dissertation research.\u00a0<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong>Jan Ellenberg,<\/strong> Head of CBB\/Head of EIC<strong>, <\/strong>and<strong> Janet Thornton, <\/strong>Group Leader and Senior Scientist,<strong> <\/strong>have both received <a href=\"https:\/\/twitter.com\/embl\/status\/1709585423654142121\">honorary doctorates from Stockholm University<\/a>, in recognition of their research achievements and roles in setting up ELIXIR Europe and Euro-BioImaging ERIC, two key infrastructures for the life sciences.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong>Anne Ephrussi<\/strong>, EMBL Senior Scientist and Director of EMBL\u2019s International Centre for Advanced Training, has been elected as one of the<a href=\"http:\/\/www.nasonline.org\/news-and-multimedia\/news\/2022-nas-election.html\"> 150 new members<\/a> of the US National Academy of Sciences. This distinction recognises her significant and continuing achievements in original research.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong>Eileen Furlong, <\/strong>Head of Genome Biology Unit and Senior Scientist, is the recipient of the<a href=\"https:\/\/alumni.ucd.ie\/magazine\/2023\/alumni-awards-2\/?fbclid=IwAR0LcUuW3QafatgRUzf1ToBndYoGYWDxoXSZ-S2oAzAThjXuatGcXlvG9R4\"> 2023 UCD Alumni Award in Research, Innovation and Impact<\/a>, awarded by the University College Dublin. The award celebrates her groundbreaking research and recognises her societal contributions.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong>Elyas Heidari<\/strong>, who was an intern in the Marioni group at EMBL-EBI between April 2021 and April 2022, working on his Master\u2019s research project, has been awarded the <a href=\"https:\/\/ethz.ch\/en\/the-eth-zurich\/education\/awards\/eth-medal\/outstanding-master-theses.html\">ETH medal for the best Master's thesis<\/a> in the department of Biological Science and Systems Engineering of ETH Zurich.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong>Henning Hermjakob, <\/strong>Head of Molecular Systems at EMBL-EBI, has been awarded the <a href=\"https:\/\/hupo.org\/HUPO-Awards-2023-Recipients\">Distinguished Service Award<\/a> by the Human Proteome Organisation, in recognition of him being an exemplary member of the proteomic research community, one whose dedicated service has made indispensable contributions to the organisation and its mission.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong>Wolfgang Huber, Julia Mahamid, and Oliver Stegle,<\/strong> who all lead research groups at EMBL Heidelberg, are among 69 life scientists elected to <a href=\"https:\/\/www.embl.org\/news\/lab-matters\/embl-scientists-elected-to-embo-membership\/\">membership of the European Molecular Biology Organization (EMBO)<\/a>. It is a lifelong honour that allows elected scientists to serve on EMBO\u2019s council and committees, evaluate applications for EMBO funding, and act as mentors to young scientists.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong>Julia Mahamid<\/strong> has also received the <a href=\"https:\/\/www.embo.org\/press-releases\/julia-mahamid-receives-embo-gold-medal-2023\/\">EMBO Gold Medal 2023<\/a>. Each year, EMBO recognises a young scientist for outstanding contributions to the life sciences in Europe. Mahamid has been awarded with this distinction for her exceptional achievements in structural cell biology and developing powerful techniques that visualise cellular machinery<em> in situ<\/em>.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong>Sandra Orchard, <\/strong>Team Leader for Protein Function Content, is one of the two recipients of the <a href=\"https:\/\/www.biocuration.org\/pascale-gaudet-and-sandra-orchard-recipients-of-the-2023-exceptional-contribution-to-biocuration-award\/\">2023 Exceptional Contribution to Biocuration Award<\/a> from the International Society for Biocuration, in recognition of her impact on and significant work for the biocuration community.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong>Georgia Rapti<\/strong>, Group Leader at EMBL Heidelberg, has been selected as a <a href=\"https:\/\/fenskavlinetwork.org\/press-release-fkne2023\/\">2023 FENS-Kavli Scholar<\/a> by the Kavli Foundation. The multidisciplinary, international network of FENS-Kavli Scholars is a group of early-career, independent neuroscience investigators, chosen for their scientific excellence, originality, and leadership. It aims to improve neuroscience in Europe and beyond through scientific exchange, advocacy, and outreach.&nbsp;<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong>Mikhail Savitski<\/strong>, Team Leader and Head of the Proteomics Core Facility at EMBL Heidelberg, has received the <a href=\"https:\/\/twitter.com\/EuPAProteomics\/status\/1642854681801097218\">EuPA Breakthrough in Proteomics Award<\/a> from the European Proteomics Association. The association presents the award annually for a breakthrough in proteomics, a discovery that transformed the knowledge frontier and has a major impact on science, technology and society.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong>EMBL <\/strong>has been awarded the <a href=\"https:\/\/www.embl.org\/news\/science\/embl-receives-german-ai-prize\/\">German AI prize<\/a> in the \u2018user\u2019 category for varied activities in applying artificial intelligence (AI) to life science research, from the AlphaFold Protein Structure Database and image analysis to omics and technology development. The prize by WELT recognises outstanding services to AI research and development as well as application and commercialisation, and the recipients were honoured at an award ceremony in Berlin in September.<\/p>\n<!-- \/wp:paragraph -->","post_title":"Awards and honours (Issue 101)","post_excerpt":"The work and excellence of EMBL researchers have been recognised with multiple awards and honours during the past six months.\n\n","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"awards-and-honours-issue-101","to_ping":"","pinged":"","post_modified":"2023-11-15 10:18:21","post_modified_gmt":"2023-11-15 09:18:21","post_content_filtered":"","post_parent":0,"guid":"https:\/\/www.embl.org\/news\/?post_type=embletc&#038;p=64101","menu_order":0,"post_type":"embletc","post_mime_type":"","comment_count":"0","filter":"raw"}],"embletc_pdf_link":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/Digital_EMBLetc_101_12pg.pdf","embletc_preview_image":{"ID":64279,"id":64279,"title":"Blank book or magazine cover on wood background","filename":"20231106_Mock-up_1000x550px.jpg","filesize":782752,"url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/20231106_Mock-up_1000x550px.jpg","link":"https:\/\/www.embl.org\/news\/embletc\/issue-101\/attachment\/blank-book-or-magazine-cover-on-wood-background-2\/","alt":"","author":"124","description":"","caption":"","name":"blank-book-or-magazine-cover-on-wood-background-2","status":"inherit","uploaded_to":63969,"date":"2023-11-08 09:00:27","modified":"2023-11-08 09:00:27","menu_order":0,"mime_type":"image\/jpeg","type":"image","subtype":"jpeg","icon":"https:\/\/www.embl.org\/news\/wp-includes\/images\/media\/default.png","width":1000,"height":550,"sizes":{"thumbnail":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/20231106_Mock-up_1000x550px-150x150.jpg","thumbnail-width":150,"thumbnail-height":150,"medium":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/20231106_Mock-up_1000x550px-300x165.jpg","medium-width":300,"medium-height":165,"medium_large":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/20231106_Mock-up_1000x550px-768x422.jpg","medium_large-width":768,"medium_large-height":422,"large":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2023\/11\/20231106_Mock-up_1000x550px.jpg","large-width":1000,"large-height":550}}},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Issue 101 | EMBL<\/title>\n<meta name=\"description\" content=\"Learn about advances in developmental biology, promiscuous proteins, the genome sequencing revolution, and much more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.embl.org\/news\/embletc\/issue-101\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Issue 101 | EMBL\" \/>\n<meta property=\"og:description\" content=\"Learn about advances in developmental biology, promiscuous proteins, the genome sequencing revolution, and much more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.embl.org\/news\/embletc\/issue-101\/\" \/>\n<meta property=\"og:site_name\" content=\"EMBL\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/embl.org\/\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-29T10:02:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2017\/07\/EMBL_logo_colour.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1638\" \/>\n\t<meta property=\"og:image:height\" content=\"783\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@embl\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.embl.org\/news\/embletc\/issue-101\/\",\"url\":\"https:\/\/www.embl.org\/news\/embletc\/issue-101\/\",\"name\":\"Issue 101 | EMBL\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/#website\"},\"datePublished\":\"2023-11-15T09:00:00+00:00\",\"dateModified\":\"2024-05-29T10:02:08+00:00\",\"description\":\"Learn about advances in developmental biology, promiscuous proteins, the genome sequencing revolution, and much more.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.embl.org\/news\/embletc\/issue-101\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.embl.org\/news\/embletc\/issue-101\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.embl.org\/news\/embletc\/issue-101\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"EMBLetc Issue\",\"item\":\"https:\/\/www.embl.org\/news\/embletc\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Issue 101\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.embl.org\/news\/#website\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"name\":\"European Molecular Biology Laboratory News\",\"description\":\"News from the European Molecular Biology Laboratory\",\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"alternateName\":\"EMBL News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.embl.org\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.embl.org\/news\/#organization\",\"name\":\"European Molecular Biology Laboratory\",\"alternateName\":\"EMBL\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"width\":300,\"height\":144,\"caption\":\"European Molecular Biology Laboratory\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/embl.org\/\",\"https:\/\/x.com\/embl\",\"https:\/\/www.instagram.com\/embl_org\/\",\"https:\/\/www.linkedin.com\/company\/15813\/\",\"https:\/\/www.youtube.com\/user\/emblmedia\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Issue 101 | EMBL","description":"Learn about advances in developmental biology, promiscuous proteins, the genome sequencing revolution, and much more.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.embl.org\/news\/embletc\/issue-101\/","og_locale":"en_US","og_type":"article","og_title":"Issue 101 | EMBL","og_description":"Learn about advances in developmental biology, promiscuous proteins, the genome sequencing revolution, and much more.","og_url":"https:\/\/www.embl.org\/news\/embletc\/issue-101\/","og_site_name":"EMBL","article_publisher":"https:\/\/www.facebook.com\/embl.org\/","article_modified_time":"2024-05-29T10:02:08+00:00","og_image":[{"width":1638,"height":783,"url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2017\/07\/EMBL_logo_colour.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@embl","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.embl.org\/news\/embletc\/issue-101\/","url":"https:\/\/www.embl.org\/news\/embletc\/issue-101\/","name":"Issue 101 | EMBL","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/#website"},"datePublished":"2023-11-15T09:00:00+00:00","dateModified":"2024-05-29T10:02:08+00:00","description":"Learn about advances in developmental biology, promiscuous proteins, the genome sequencing revolution, and much more.","breadcrumb":{"@id":"https:\/\/www.embl.org\/news\/embletc\/issue-101\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.embl.org\/news\/embletc\/issue-101\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.embl.org\/news\/embletc\/issue-101\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"EMBLetc Issue","item":"https:\/\/www.embl.org\/news\/embletc\/"},{"@type":"ListItem","position":2,"name":"Issue 101"}]},{"@type":"WebSite","@id":"https:\/\/www.embl.org\/news\/#website","url":"https:\/\/www.embl.org\/news\/","name":"European Molecular Biology Laboratory News","description":"News from the European Molecular Biology Laboratory","publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"alternateName":"EMBL News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.embl.org\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.embl.org\/news\/#organization","name":"European Molecular Biology Laboratory","alternateName":"EMBL","url":"https:\/\/www.embl.org\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","width":300,"height":144,"caption":"European Molecular Biology Laboratory"},"image":{"@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/embl.org\/","https:\/\/x.com\/embl","https:\/\/www.instagram.com\/embl_org\/","https:\/\/www.linkedin.com\/company\/15813\/","https:\/\/www.youtube.com\/user\/emblmedia\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/issue\/63969","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/issue"}],"about":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/types\/embletc-issue"}],"wp:attachment":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media?parent=63969"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}